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ABSTRACT 
In 2017, the United States Department of Health and Human Services (HHS) 
declared the opioid epidemic a public health emergency. The opioid epidemic has 
become widespread because of over prescription and extreme addiction. In recent years, 
the crisis has become dire because of the staggering annual death toll from overdoses. 
Although the number of opioid-related deaths has risen, so too have the innovations 
designed to combat opioid abuse and overdoses. The use of naloxone is a safe and 
reliable option for treating overdose victims. In fact, many first responders are primarily 
relying on the medication in such emergencies. This study explored message-design 
components for persuading individuals to purchase Narcan nasal spray (a Nalaxone 
product). Guided by the Extended Parallel Process Model, the project employed three 
message framing techniques, including gain-frame/loss-frame, labeling and medical 
stigmatization through language, and linguistic agency assignment. 304 participants read 
one of eight messages and completed a corresponding survey. The first measure of 
behavioral intent, which was acceptance or refusal of the coupon code for the Narcan 
nasal spray, was predicted only by susceptibility and system-efficacy. The second 
measure, intent to seek additional information regarding Narcan, was predicted by 
severity, susceptibility, and system-efficacy. The third measure, intent to own Narcan in 
the future, was predicted by susceptibility and response-efficacy. Optimistic bias and 
self-efficacy did not predict any of the three behavioral intent variables. However, when 
separate from the other independent variables, optimistic bias predicted all three 
behavioral intent variables. 
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CHAPTER I - INTRODUCTION 
The Opioid Crisis 
In 2017, the United States Department of Health and Human Services (HHS) 
declared the opioid epidemic a public health emergency (HHS, 2018a). Alex Azar, 
Secretary of HHS, described the opioid crisis in this way:  
The opioid misuse and overdose crisis touches everyone in the United States.  
In 2016, we lost more than 115 Americans to opioid overdose deaths each  
day, devastating families and communities across the country. Preliminary  
numbers in 2017 show that this number continues to increase with more than 131  
opioid overdose deaths each day. The effects of the opioid crisis are cumulative  
and costly for our society—an estimated $504 billion a year in 2015—placing  
burdens on families, workplaces, the health care system, states, and communities. 
(HHS, 2018b, p. 1).   
The general knowledge of opioids is growing as the number of people dependent 
on the medications increases. According to the American Psychiatric Association (2018), 
nearly one in three Americans knows at least one person addicted to opioids. Opioids are 
a class of pain-relieving drugs that interact with opioid receptors in the body to calm 
nerves, sometimes creating a feeling of euphoria for the recipient that can become very 
addictive, according to the National Institute on Drug Abuse (2018a). Again, this sharp 
rise in the abuse of opioids and overdose deaths is what led the HHS and other 
government agencies to declare the trend an epidemic.   
The Centers for Disease Control and Prevention (CDC) attribute the rise of the 
epidemic to three distinct waves of opioid use and abuse. First, there was an initial rise in 
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medical providers prescribing opioids in the 1990’s (CDC, 2017a). According to Liu, Pei, 
and Soto (2018) “the increase in opioid prescriptions was influenced by reassurances 
given to prescribers by pharmaceutical companies and medical societies claiming that the 
risk of addiction to prescription opioids was very low” (para. 1). The second uptick in the 
use of opioids resulted from a rapid increase in deaths from heroin around 2010. The 
increase in heroine-related deaths partially originated from regulatory efforts making 
prescription opioids harder to obtain; instead, individuals struggling with addiction 
sought means other than prescriptions to obtain opioids (CDC, 2017 a).   
Finally, the most recent wave of the epidemic is due to an increase in deaths due 
to illicitly-manufactured opioids, such as fentanyl, in 2013 (CDC, 2017a). Fentanyl is 
typically used for treating advanced cancer pain and is 50 to 100 times more potent than 
morphine (CDC, 2017b). This third wave is particularly dangerous as “the illicitly-
manufactured fentanyl (IMF) market continues to change, and IMF can be found in 
combination with heroin, counterfeit pills, and cocaine” (CDC, 2017a, para. 6). 
According to the U.S. Drug Enforcement Agency (n.d.), “many users believe that they 
are purchasing heroin and actually don’t know that they are purchasing fentanyl – which 
often results in overdose deaths” (para. 1). As the market for opioids continues to grow 
and evolve, it is critical to address the crisis to prevent a fourth, deadlier wave in the 
future. 
Opioid addiction 
The opioid epidemic has become widespread because the drugs are 
overprescribed and are also extremely addictive (CDC, 2017c). The American Addiction 
Centers (2019) report that 9.7% of women and 12% of men admit to using Oxycontin or 
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Vicodin while at work. An additional 1% of women and 1.5% of men admit to using 
heroin while at work (AAC, 2019). Although heroine is an illicit drug, other forms of 
opioids like Oxycontin or Vicodin are regulated prescriptions that can be obtained from 
physicians. Not surprising then that the CDC reports that one in four patients receiving 
long-term opioid therapy will struggle with an addiction to the drug (CDC, 2017c).   
Pharmaceutical companies have benefited greatly from the widespread 
prescribing of opioids, and in some cases, they engaged in legally questionable actions to 
keep them on the shelves. In fact, Purdue Pharma, the company that manufactures the 
opioid product OxyContin, lied to the public and other stakeholders about the true 
addictive nature of the drug (Mole, 2018). After pleading guilty in a lawsuit, the family 
that owned Purdue Pharma then quietly started a second company called Rhodes Pharma, 
manufacturing generic brands of the same product. In 2019, both companies are being 
sued by New York and other states for “putting hunger for profits over patient safety” 
(Associated Press, 2019, par 1). The state of New York alone is asking for tens of 
millions of dollars, as well as requiring the companies to establish a fund to curb the 
crisis in the state. Oklahoma settled its lawsuit with Purdue Pharma for $270 million 
(Wildeman, 2019).   
The opioid crisis has become so dire that the Food and Drug Administration 
(FDA) has warned veterinarians to be aware of people trying to get opioid prescriptions 
for their pets with the intention of using the pills or distributing them to others (FDA, 
2018). As the number of those addicted grows, users will go to great lengths to obtain 
more opioids. In some cases, theft behavior evolves in parallel with the development of 
compulsive drug use behavior. As casual experimentation gives way to full-blown 
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addiction, the need to obtain and use that substance takes priority over everything else in 
life. People don’t behave like themselves and will go to great lengths to get more of the 
drug – even if that means stealing from friends and family (AAC, n.d., para 12).  
The overprescribing of opioids cannot be understated in its contribution to the 
crisis. In 2017, more than 191 million prescriptions were dispensed in the United States 
alone, or nearly 1.5 prescriptions per household annually (CDC, 2017d). In 2011, the 
opioid medication hydrocodone was the most prescribed pharmaceutical with 131.2 
million prescriptions. The second most prescribed drug in 2011, a cholesterol-lowering 
medication, was prescribed nearly 40 million times less than hydrocodone (DeNoon, 
2011). Seven years later, even after a nationwide-push for physicians to treat pain in ways 
other than prescribing opioids, hydrocodone remained the highest prescribed medication 
in several states, including Alabama, Alaska, Georgia, Idaho, Indiana, Illinois, 
Mississippi, Nebraska, Oklahoma, and South Carolina (Goetz, 2018). Additionally, in 
Tennessee, the top prescribed drugs are buprenorphine and naloxone, medications used to 
help those with opioid addiction (Goetz, 2018).   
Complicating the overprescribing of opioids is the finding that approximately 
28.5% of prescriptions are distributed without any pain-related justification from the 
prescribing providers (Sherry, Sabety, & Maestas, 2018). Based on the number of 
prescriptions cited above, in 2017 alone, approximately 955,000 opioid prescriptions 
were given without any clinical justification. Further, pharmaceutical industry marketing 
has spent large sums of money specifically targeting physicians, a practice that has 
directly resulted in higher overdose rates (Hadland, Rivera-Aguirre, Marshall, & Cerdá, 
2019). The marketing tactics include providing meals for physicians, a practice that has 
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led to increased prescribing (Gershman, 2019). Although marketing drugs to physicians 
is very common, Purdue Pharma understood the extremely addictive nature of opioids as 
early as 1999 (Keshner, 2018). The company failed to disclose the information to 
physicians and regulators while continuing to market the drugs (Meier, 2007).    
While prescription opioids have garnered much attention, heroin is also extremely 
potent and addictive. It is also more likely that people will misjudge the amount of heroin 
being consumed because of its unregulated production and distribution (AAC, 2018a). 
While some pervasive cultural assumptions point to minorities and lower socio-economic 
persons as primary users, recent surges in heroin use has been attributed more to women, 
non-Hispanic whites, and people with private health insurance (Jones, Logan, Gladen, & 
Bohm, 2015). Both legal and illegal opioid addiction can destroy lives of people from all 
races, genders, and classes.   
To curb the opioid crisis, the US House of Representatives passed a bill directing 
the National Institutes of Health to develop non-addictive painkillers, change the way 
prescription pills are distributed, and require the inclusion of addiction history in patient 
medical records as of June of 2018. The bill also provides agencies with additional tactics 
for preventing the transport of opioids into the United States (Sotomayor, 2018).  
The CDC also released a new set of opioid prescription guidelines for chronic 
pain (CDC, 2018). Although some lawmakers advocated for a hard cap to the amount of 
prescriptions physicians can prescribe, there are drawbacks to this type of regulation. For 
example, chronic pain sufferers fear that strict regulations for opioid prescribing practices 
may worsen their quality of life (Joyce, 2018). There are two competing needs at play: 
The need to address the growing opioid epidemic and the need to provide care for people 
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with chronic pain. As one chronic pain patient stated, “It's the difference between laying 
[SIC] in bed crying and getting up and going kayaking” (Joyce, 2018, para. 1). “We are 
not criminals, we are just in pain” (para. 5). 
Opioid related deaths 
In recent years, the crisis has become dire because of the staggering annual death 
toll from opioid overdose (NIDA, 2018b). Over two million people in the United States 
currently suffer from an opioid dependency (Wolf, 2019), and this opioid dependency 
increases their risk of experiencing an early death by 19.8% (Hser et al., 2017). An 
overdose occurs when too many opiates attach to the opioid receptors in the brain, and 
breathing is suppressed to a dangerously low rate, or even stopped completely (White & 
Irvine, 1999). According to the CDC (2017a), the number of opioid-related deaths in 
2016 soared above 63,600. Opioids are now cited as one of the top contributing factors 
for the unprecedented life expectancy decline in the United States (Thompson, 2018). 
While the unregulated nature of heroin has contributed to deaths, an estimated 40% of 
overdose cases result from prescription opioids (CDC, 2017c).   
Interestingly, the elderly population experiences a high risk of opioid overdose. 
“As the baby boomer generation ages and the population of older adults in the United 
States grows, opioid misuse among older Americans is becoming an increasingly urgent 
public health concern” (SAMHSA, 2017a, p. 1). While Malec and Shega (2015) reveal 
that the addiction risk is lower in the elderly population, older patients are often 
overprescribed pain-relieving medication in quantities far surpassing manufacturer 
recommendations (AAC, 2018b). Finally, as people age, their memory can deteriorate, 
potentially increasing the risk of overdose. “[The elderly] might not fully hear their 
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doctor’s instructions, they might take the wrong dose, or forget if they took it already—
all of which can lead to misuse, significant negative side effects, or even overdose” 
(AAC, 2018b, para 3).   
The CDC has focused on four tactics to prevent opioid overdose. The first tactic is 
to improve prescription practices through clearer clinical guidelines. “Recommendations 
focus on the use of opioids in treating chronic pain outside of active cancer treatment, 
palliative care, and end-of-life care” (CDC, 2017f, para 2). The second tactic is 
preventing opioid use disorder by preventing exposure to the drug through prescription 
monitoring programs, state prescription laws, formulary management strategies in 
insurance programs, provider education, patient education, quality improvement 
programs in health care systems, and generally raising awareness (CDC, 2017g). The 
third approach is treating those with opioid use disorder with evidence-based treatments 
such as medication-assisted therapy. Medication-assisted therapy is a comprehensive 
treatment that combines the use of medications such as methadone, buprenorphine, or 
naltrexone to assist individuals to stop using opioids. This approach is often coupled with 
counseling and behavioral therapy (CDC, 2017h). The final approach is to actively 
reverse overdose occurrences using Naloxone, the medication employed to immediately 
reverse the fatal results of opioid overdoses (CDC, 2017i).  
Naloxone 
Although the number of opioid-related deaths has risen, so too have the 
innovations designed to combat opioid abuse and overdoses. For instance, suboxone was 
designed to curb opioid addiction withdrawal as people attempt to stop using the drugs. 
However, likely the greatest weapon against opioid-related deaths is the drug Nalaxone, 
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which has been used by first responders and medical centers (Sauers, 2019) to rapidly 
reverse and block the adverse effects of an opioid overdose, thereby quickly returning the 
respiration rates of the victim to normal measures (NIDA, 2018c).   
Nalaxone was originally discovered and patented in 1961 to treat constipation 
caused by chronic opioid use (Cordant Health Solutions, 2017). Second, the FDA 
approved the drug as an overdose treatment in 1971. Finally, the first take-home kits for 
laypersons were distributed as a pilot program in 1996. As of 2015, over 26,000 lives had 
been saved thanks to naloxone (Wheeler, Jones, Gilbert, & Davidson, 2015). Weiner, 
Baker, Bernson, and Schuur (2017) measured the overall success of the drug and revealed 
that naloxone saved the victim 93.5% of the time, and 84.3% of survivors were still alive 
one year later.    
The use of naloxone is a safe and reliable option for treating victims of opioid 
overdose. In fact, many first responders are primarily relying on the medication in 
overdose emergencies (NPR, 2018). There are no life-threatening side effects to 
naloxone, only minor discomfort after being revived (NIDA, 2018c). However, certain 
stakeholders including various first responders and media outlets remain uneducated 
about the properties of Naloxone and its ease of use. This has unfortunately slowed the 
diffusion of this particular innovation (Bagley & Bright, 2018).   
Because of the lack of available information regarding the life-saving drug, as 
well as the fear of potential consequences for requesting or possessing Naloxone (Green 
et al., 2017), some have expressed some uneasiness surrounding the medication. 
However, given the staggering number of opioid overdose-related deaths occurring every 
day in the United States, it is imperative that health communicators develop messages 
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that educate the public and first-responders as well as managing misinformation 
surrounding Naloxone. In other words, communicators must craft messages that inform 
the public about the drug while persuading them—especially those with friends or family 
members who have struggled with an opioid addiction—to carry it regularly.   
The current study explores message-design components for persuading 
individuals to purchase the Narcan nasal spray (a Nalaxone product). Guided by the 
Extended Parallel Process Model (EPPM), the project employs three message framing 
techniques, including gain-frame/loss-frame, labeling and medical stigmatization through 
language, and the linguistic agency assignment. The following chapter provides an in-
depth review of literature concerning the theoretical framework, message design 
components, and health communication campaign techniques. 
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CHAPTER II – LITERATURE REVIEW 
Health Communication Campaigns 
The National Cancer Institute (2002) developed a four-stage process for 
developing health communication campaigns. These stages include campaign planning, 
message design and testing, campaign implementation, and evaluation. The first two 
stages, campaign planning and message design and testing, are most pertinent to the 
current study. In terms of planning and strategy development, communication campaign 
designers should first conduct a conceptual analysis (Silk, Atkin, & Salmon, 2011) to 
better understand the public health concern. In this phase of planning, the target audience 
should be identified (Randolph & Viswanath, 2004) along with the focal segment(s) and 
focal behavior(s) (Silk, Atkin, & Salmon, 2011). Focal segmentation refers to distinct 
groups in the population that need to change a specific health behavior. For campaign 
purposes, focal segmentation parameters must be established. For example, a recent e-
cigarette campaign experiment targeting three different groups (old smokers, reluctant 
smokers, and young smokers), established demographic, cognitive, and behavioral 
parameters before sampling (Yang, Liu, & Popova, 2018).    
Focal behaviors are the health-related behaviors that need to be adopted or 
discontinued by the focal segment. The behavior focus should always be a specific, 
discrete action (Atkin, 2001). Campaign designers must decide whether to focus on 
encouraging target audiences to add or eliminate related behaviors (Perloff, 2010). For 
example, a campaign in Denver promoted the prevention of sexually transmitted diseases 
and identified male and female condom use as the main focal behavior for the campaign 
(Salyers Bull, Cohen, Ortiz, & Evans, 2002). The campaign focused specifically on 
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encouraging condom use for those not already engaging in the behavior.  Once the focal 
segments and focal behaviors are established, campaign designers should identify the 
determinants, including attitudes, beliefs, knowledge, social influences, and 
environmental forces that contribute to health behaviors (Silk, Atkin, & Salmon, 2011). 
Identifying these social determinants can assist campaign designers in identifying the 
most promising pathways and developing campaign objectives (NCI, 2002; Silk, Atkin, 
& Salmon, 2011).     
The second stage of the campaign process is pretesting concepts, messages, and 
materials. Developing the right message can make or break a campaign. When 
implemented poorly, health campaigns may fail to meet goals and can even lead to 
boomerang results, or outcomes directly opposed to intended goals (Dillard & Shen, 
2005). Several variations of the campaign message(s) should be created and tested on a 
small sample of the focal segment. Knowing which messages will be most effective will 
save program campaign resources by ensuring that the process is not implemented with 
an ineffective message (NCI, 2002).    
In health and risk message design, rigorous approaches “determine which 
variations matter for whom and in what contexts, with the ultimate goal of designing 
more effective persuasive messages to have a positive impact on health behavior” 
(Harrington, 2015, p. 103). O’Keefe (2015) argues that all message design choices should 
be evidence-based, specifying that evidence should come from replicated trials, effect 
sizes, and random-effects meta-analysis.  
Another integral characteristic to any campaign is its credibility (Iyengar & 
Valentino, 2000). Message designers should ensure that the source of the message is 
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perceived as credible by the focal segment. Source credibility can be defined as “the 
extent to which the information and advice came from a knowledgeable source, was 
prepared by an expert, seemed impartial, and was readily available” (Briggs, Burford, De 
Angeli, & Lynch, 2002, p. 328). High perceptions of source credibility often lead to 
higher perceptions of self-efficacy, perceptions of threat severity, and behavioral 
intention rates (Phua, 2016; Haase, Betsche, & Renkewitz, 2015; Kareklas, Muehling, & 
Weber, 2015). Health-related messages must also include sufficient evidence to establish 
the seriousness of the threat. Additionally, special attention should be paid to the 
evidence employed in messages to ensure that the campaign messages do not backfire, 
resulting in unintended consequences for the campaign (Silk, Atkin, & Salmon, 2011).   
The current project focuses on the message design components that may influence 
individuals’ likelihood to alter their behavior for the safety of others, including their 
friends and family members. In most cases, someone experiencing an opioid overdose is 
unlikely to have the presence of mind or the physical ability to administer Narcan to 
themselves. Therefore, developing compelling messages that encourage others to carry 
Narcan, not simply individuals dependent on opioids, is the intent of the current study. 
While there are few examples of Narcan-centered health communication campaigns, 
there has been a recent surge of opioid-centered campaigns in the United States sparked 
by the widespread opioid crisis. 
Opioid health communication campaigns 
Attempts to address the opioid crisis using health communication campaigns have 
emerged at the national, state, and even local levels. At the national level, the CDC 
(2019) created its national campaign entitled “Rx Awareness,” with a goal to “increase 
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awareness that prescription opioids can be addictive and dangerous and to decrease the 
number of individuals who use opioids recreationally or overuse them” (CDC, 2019, 
para. 1). The campaign employs stories from real people affected by opioids either 
directly or indirectly. The White House also released its own campaign called “The Crisis 
Next Door” that allows victims to upload their own videos to share their experiences with 
others in hopes of preventing addiction and providing help (Office of National Drug 
Control Policy, 2019).  
As of June 2017, the Substance Abuse and Mental Health Services Administration 
(SAMHSA) had identified 15 state-wide communication campaigns addressing the 
opioid crisis in 12 different states (SAMHSAb, 2017). These state-wide opioid 
campaigns include the “Dose of Reality” campaign in Minnesota, the “Anyone, 
Anytime” campaign in New Hampshire, the “North Dakota Prescription Drug Abuse 
Campaign” in North Dakota, the “Prescription for Prevention” campaign in Ohio, the 
“OvedoseFreePA.org” campaign in Pennsylvania, the “Use Only as Directed” campaign 
in Utah, the “Vermont’s Most Dangerous Leftover” campaign in Vermont, the “Sink or 
Swim” campaign in Virginia, and the “Dose of Reality” and “Good Drugs Gone Bad” 
campaigns in Wisconsin. Some of the campaigns established specific target audiences. 
Three campaigns specifically targeted young people, including public service 
announcements in Delaware targeting persons 12-25, the Generation RX Project in 
Georgia targeting persons 12-25, and public service announcements in Maryland aimed at 
persuading college students. Finally, the “Parent Up” campaign in Vermont targeted 
parents, and the “Don’t Run, Call 911” campaign in Delaware targeted overdose victims. 
Finally, cities and municipalities have also increased communication campaign efforts to 
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curb the crisis, such as the Opioids Solutions RVA campaign in the Richmond Virginia 
area (Rojas, 2019).    
Message design is critical for campaign success, and messages should increase 
people’s knowledge surrounding a health threat while also encouraging them to modify 
their behavior through persuasive tactics (NCI, 2002). For example, in the CDC’s 
Awareness RX campaign, one of the campaign messages features a picture of a pill bottle 
accompanied by the quote “Prescription opioids can be addictive and dangerous. It only 
takes a little to lose a lot” (CDC 2017e, para. 2). This message is intended to increase 
readers’ knowledge more than modify their behavior by raising awareness to the inherent 
dangers of opioid use. In another campaign message, a picture of a woman is captioned 
with the quote “I’m not supposed to be the one to pick which sneakers I’m going to bury 
him in” (CDC, 2017d, para. 3). This message is intended to conjure mental images of the 
woman burying her son, and the message designers are trying to invoke the readers’ 
emotions while persuading them of the danger posed by opioids.   
Health campaign messages should increase the knowledge of the audience while 
persuading individuals that they are at risk for the given threat. The theoretical 
framework of the EPPM explains how constructing messages that cause people to feel 
susceptible to certain risks may serve as a catalyst for behavior change. The following 
section provides an overview of the theoretical tenets of the EPPM. 
Extended Parallel Process Model 
Developed by Kim Witte (1992), the EPPM was modeled to explain how people 
process fear appeal messages (Lewis, Watson, & White, 2013). The basic premise of the 
EPPM is that a message recipient is more likely to adopt a recommend behavior 
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change when both the perception of threat and the perception of efficacy are high. The 
EPPM has been used in many contexts, including the H1N1 virus and its corresponding 
vaccine (McGlone, Bell, Zaitchik, & McGlynn III, 2013), germs from urine and feces and 
hand-washing (Botta, Dunker, Fenson-Hood, Maltarich, & McDonald, 2008), 
cardiovascular disease and proper vitamin intake (McKay, Berkowitz, Blumberg, & 
Goldberg, 2004), radon and radon abatement systems (Dragojevic, Bell, & McGlone, 
2014), and others (Witte & Allen, 2000). 
Previous fear appeal models 
For decades, scholars have investigated the role of fear on human behavior 
(Dillard, 1994; Witte, 1992). The first phase of fear appeal theories and research was 
focused on the drive models. The drive models situate fear as a “stimulus-producing 
response that has the functional properties of a drive” (Janis & Feshbach, 1953, p. 90). 
The drive models are a four-step process that begin with 1) the individual receiving a fear 
appeal message, 2) the individual experiencing an arousal of fear, 3) the individual 
wanting to reduce the level of fear, and 4) the individual changing his or her attitude or 
behavior (see figure 1; Dillard, 1994).  
In early fear appeal literature, scholars assumed greater levels of fear resulted in a 
greater intent to control the danger. In other words, “One would predict that the group 
displaying the greatest degree of residual fear would be most strongly motivated to ward 
off those internal symbolic cues which [are] salient during and immediately after the 
communication” (Janis & Feshback, 1953, p. 90).  However, there were problems with 
drive models that pushed scholars to develop a more comprehensive approach better in 
explaining the cognitive and emotional aspects of fear appeals (Dillard, 1994). Leventhal  
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Figure 1. Original Drive Model  
(Dillard, 1994) 
(1970) offered several critiques of drive models, including the lack of scholarly evidence 
that fear is the mediator of attitude or behavior change, the lack of specific variables 
capable of changing the optimal level of fear, and the lack of research supporting the 
capability of drive models to function as anything beyond a low-order descriptive 
hypothesis.  
To address his own objections to the drive models, Leventhal (1970) proposed the 
parallel response model (PRM) (see figure 2). The PRM posits that once a fear appeal is 
encountered, audiences will engage in two succinct reactions. First, an individual will 
simultaneously experience an awareness of danger and the creation of fear. Next, the 
individual will attempt to control both the danger and the fear. While distinct processes, 
the fear response and danger response may impact one another in either a facilitative (i.e. 
when danger-control efforts reduce fear) or disruptive (i.e. when fear-control efforts 
prevent danger-control efforts) manner. 
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Figure 2. Parallel Response Model 
(Dillard, 1994).  
However, because of several shortcomings to the PRM, including its lack of 
precision “in specifying what conditions lead to danger or fear control processes” (Witte, 
1992, p. 333), a new wave of fear appeal theories, known as the expectancy value 
theories, emerged. The most notable include the Protection Motivation Theory (PMT) 
(Rogers, 1975) and the Subjective Expected Utility Theory (SEU) (Sutton, 1982). These 
models “deemphasized the role of fear arousal in favor of cognition” (Witte, 1992, p. 
334). Ultimately, decades of research on fear appeals would inform the creation of the 
Extended Parallel Process Model, a more comprehensive explanation of fear and danger 
control responses.    
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Fear appeals are often used in health communication campaigns, and they can be 
defined as, “persuasive communication that attempts to arouse fear in order to promote 
precautionary motivation and self-protective action” (Ruiter, Kessels, Peters, & Kok, 
2014, p. 65). Health campaigns that employ fear appeals “are based on the assumption 
that by vividly demonstrating negative and life-endangering consequences of risk 
behaviors, people will be motivated to reduce their current risk behavior and adopt safer 
alternative behaviors” (Ruiter, Kessels, Peters, & Kok, 2014, p. 63).   
Most fear appeals are employed to accomplish two purposes. First, an effective 
fear appeal should present a threat perceived to be dangerous by the message recipient. 
Second, the message should present a viable option for averting the threat (Witte, 1992; 
Witte & Allen, 2000; Ruiter, Kessels, Peters, & Kok, 2014). For example, a fear appeal 
message used in a texting and driving campaign would present the threat of people killing 
either themselves or someone else in a distracted driving incident. Next, an appropriate 
behavior for averting the threat, which could include mobile driving applications or 
simply a commitment to quit texting, would be presented. The success of this fear appeal 
would depend heavily on the audience’s perception of the threat presented in the 
message. Threat perception can be measured through perceived severity and 
susceptibility. When trying to persuade individuals to engage in the prescribed behaviors, 
messages should include strong efficacy components. Specifically, messages should 
convey strong perceptions of self-efficacy and response-efficacy for message recipients. 
In the presence of fear appeals, audience members need reinforced messages of efficacy 
to engage in the prescribed behaviors. 
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Perception of threat severity and threat susceptibility 
Strong threat components in fear appeals produce high levels of both severity and 
susceptibility for message recipients (Witte & Allen, 2000). Witte and Allen (2000) 
define severity as “the magnitude of harm expected from the threat” (p. 592) and 
susceptibility as “the degree to which one feels at risk for experiencing the threat” (p. 
592). The first proposition of the EPPM is that if the combination of these two 
components results in a low overall perception of threat then there will be no further 
processing of the message, ultimately resulting in a failed attempt to change behavior 
(Witte, 1992). While these components primarily focus on the perception of threat to 
one’s self, research shows that threats to others can also motivate people to act (Sampson 
et al., 2001). This can be referred to as perceived threat to others (Roberto, Murray-
Johnson, & Witte, 2011). For example, persuading a new mother not to put blankets or 
pillows in a crib with a newborn in order to avoid suffocating the child could be 
successful, not because the mother is afraid of suffocating, but because she is afraid of 
her newborn suffocating.   
Ruiter, Kessels, Peters, and Kok (2014) argue that while severity is often the most 
visible component in fear appeals, it is also the least persuasive. A threat may appear to 
have very intimidating consequences, but if the message recipient does not feel 
susceptible, they are unlikely to experience a high level of fear (Witte, 1992). Thus, 
people are unlikely to change their behavior unless they feel susceptible to a particular 
risk. For the current study, threat severity measured participants’ perception of the opioid 
crisis, and how harmful it could be to their loved ones. Threat susceptibility measured 
participants’ perception of the likelihood that their loved ones could be a victim of the 
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opioid crisis. Both are measurements of perceived threat to others and not perceived 
threat to self. 
Perception of self-efficacy and response-efficacy 
Self-efficacy is defined as “people’s beliefs about their capabilities for exercising 
control over their own level of functioning and over events that affect their lives” 
(Schreurs, Van Emmerik, Notelaers, & De Witte, 2010, p. 60). Response-efficacy is 
defined as “belief as to whether a response effectively prevents the threat” (Witte, 1992, 
p. 332). Together, these two components create an overall perception of efficacy. One of 
the main propositions of the EPPM is that a low perception of efficacy (when perception 
of threat is high) will result in a boomerang effect, ultimately resulting in the message 
recipient choosing not doing what is being advocated in the message (Witte, 1992). 
Therefore, a health campaign message that focuses only on the severity of the threat and 
the target population’s susceptibility to it is likely to fail. There must also be a focus on 
efficacy.   
In the current study, the recommended behavior change is persuading people to 
carry Narcan nasal spray (the brand name for the naloxone medication used in the 
message) so they are prepared in the event of a loved one overdosing. Therefore, self-
efficacy will measure participants’ perception that they themselves can help their loved 
ones in an overdose emergency. Likewise, response-efficacy will measure the 
participants’ perception that Narcan nasal spray is an effective response to an opioid 
overdose. 
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Perception of system-efficacy 
The current study also considers system-efficacy and how it contributes to 
individual behavioral intention. System-efficacy is defined as the belief that the society 
one belongs to can provide effective support and/or mitigate harm (Venette, 2008; 
Anthony, Venette, Pyle, Boatwright, & Reif, 2018; Macpherson et al., 2014). 
Fundamentally, if an individual lacks trust in some part of the system to which they 
belong (family or society for example), their lack of trust affects whether or not they 
regard or adhere to recommendations advocated by members of the system.   
Having a low perception of system-efficacy might stem from several factors 
including a belief that an entity within the system (i.e., perceptions of Purdue Pharma 
among families dealing with opioid dependence) does not have the best intentions. For 
example, the core issue of an individual who questions the practice of vaccinating 
children might be their perception that the government or pharmaceutical companies do 
not have their best interest in mind. This low perception of system-efficacy might lead 
them to reject what is being advocated regardless of any other information or evidence. 
Alternatively, people may perceive that an entity may not have the necessary resources to 
help. For instance, the core issue of an individual who decides not to call a suicide 
prevention hotline may simply believe that the group responding does not have the ability 
or resources to help them overcome their situation. In both examples, while different, the 
individual does not have faith that the system that they belong to can help them overcome 
the threat they are facing. For the current study, system-efficacy will measure the 
participants’ belief that first responders, pharmaceutical companies, family members, 
 22 
friends, etc., can help mitigate the harm created by the opioid crisis for themselves and 
the people around them. 
Danger-control response and fear control response 
Response, the final concept in the EPPM, is the reaction to the fear appeal. 
Message recipients will respond in one of three ways: No response, fear-control response, 
or danger-control response (Witte, 1992). If the threat component of the message does 
not induce fear in the recipient, he or she will likely have no response to the message, 
rendering it ineffective. If the threat component does induce fear, but the recommended 
action is not efficacious to the listener, the recipient will likely experience a fear-control 
response. When individuals experience a fear-control response, they may rationalize the 
threat as not harmful to them. In essence, they are controlling their fear by convincing 
themselves that they are not in danger. This may result in individuals avoiding 
recommended actions or even concluding that the recommended behavior change is 
ineffective.   
However, if the threat component of the message induces fear and the 
recommended action is perceived as efficacious, the recipient will be more likely to react 
with a danger-control response. A danger-control response often results in the message 
recipient engaging in the recommended action. Given this response, individuals decide 
that they are in real danger and need to act to weaken their susceptibility to the threat. 
They realize that they can take precautionary measures by adhering to the recommended 
behaviors. In other words, without clear messages promoting self-efficacy and response-
efficacy, individuals may attempt to control their fear through rationalization rather than 
controlling the actual threat by changing their behavior. 
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Figure 3. Extended Parallel Process Model 
(Witte, 1992) 
Optimistic Bias 
Optimistic bias is the tendency for an individual to believe that he or she is less at 
risk of a threat than the average person; optimistic bias reveals the ways individual 
judgements of risk are subjective (Turner, Skubisz, & Rimal, 2011). For example, 
smokers and non-smokers alike believe that other people are more likely die from 
smoking cigarettes than they are themselves (Arnett, 2000). Interestingly, subjective 
judgements, like the smoking example, nearly always reveal lower—not higher—
individual perceptions of susceptibility (Turner, Skubisz, & Rimal, 2011). Rogers (1998) 
argues that humans display optimistic bias not only when considering potentially 
negative outcomes (i.e., a greater likelihood that bad things will happen to others instead 
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of themselves), but also in considering potentially good outcomes (i.e., a greater 
likelihood they could win the lottery over others). The optimist bias phenomenon is 
apparent even in populations most at risk. For instance, African American teenagers 
report perceiving that they are less likely to become pregnant or cause pregnancy when 
being sexually active than the “average person” (Chapin, 2001); however, in actuality, 
African American teenagers consistently experience higher than average rates of teen 
pregnancy when compared to other demographic groups (HHS, 2019).   
Although scholars as early as Lund (1925) investigated individuals’ beliefs about 
future events, Weinstein (1980) first fully articulated the optimistic bias phenomenon. In 
this first study, when asked about the likelihood of future events, students rated their own 
likelihood of experiencing positively valanced events as higher than that of their 
classmates. For life events perceived to be negative, the students rated their classmates’ 
likelihood of experiencing the events as higher than their own. Recently, scholars have 
shown that individuals experience optimistic bias with foodborne disease (Rossi, 
Stedefeldt, da Cunha, & de Rosso, 2017), investment outcomes (Wu, Liu, Han, & Yin, 
2018), high blood pressure and obesity (White et al., 2017), cancer and cardiovascular 
disease (Masiero, Riva, Oliveri, Fioretti, & Pravettoni, 2018), bladder cancer (Riva, 
Masiero, Mazzocco, & Pravettoni, 2018), and others (see Table 1). 
Several explanations have been offered over the years as to why optimistic bias 
exists (Turner, Skubisz, & Rimal, 2011), including that optimistic bias serves as a tool to 
help alleviate anxiety from more realistic expectations of susceptibility (Kirscht, Haefner, 
Kegeles, & Rosenstock, 1966). Additionally, optimistic bias has been explained through 
the “Muhammad Ali Effect,” or the idea that “people wish to hold positive beliefs about 
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Table 1 Instances of Optimistic Bias found in the Current Literature 
Article Threat Population 
Kim & Hancock, 2015 Negative Social and 
Psychological Outcomes of 
Facebook 
Facebook Users 
Park & Ju, 2016 Alzheimer’s Disease Adults 65 and older 
Chapin & Coleman, 2017 Cyberbullying 7th-12th Graders 
White, et al., 2017 High Blood Pressure and 
Obesity 
African American 
Adolescents 
Rossi, Stedefeldt, da 
Cunha, & de Rosso, 2017 
Foodborne Disease Food Handlers 
Riva, Masiero, Mazzocco, 
& Pravettoni, 2018 
Bladder Cancer Young Adults 
Masiero, Riva, Oliveri, 
Fioretti, & Pravettoni, 2018 
Cancer and Cardiovascular 
Disease 
Young Adults 
Wu, Liu, Han, & Yin, 2018 Investment Outcomes Analysts 
Hwang, et al., 2019 COPD Male Smokers 
Drouin, Winickoff, & 
Thorndike, 2019 
Tobacco Use and Obesity Parents  
Andrade, Rodrigues, 
Antongiovanni, & de 
Cunha, 2019 
Foodborne Disease Food Handlers and 
Consumers 
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themselves. These beliefs are often that they are at least average on important dimensions 
and possibly above average” (Allison, Messick, & Goethals, 1989, p. 289). However, a 
more recent explanation for optimistic bias posits that when asked to compare ourselves 
to others, we often believe that we experience less risk than others for certain negative 
consequences (Rimal & Morrison, 2006).   
Finally, another recent and simpler explanation is that individuals feel more 
positivity about their own behaviors than the behaviors of others (Turner, Skubisz, & 
Rimal, 2011). Perhaps another way to understand this explanation is through the 
fundamental attribution error, which asserts that humans will blame negative actions of 
themselves on external factors while blaming negative actions of others on internal 
factors (Ross, 1977). For instance, if a person is asked to compare the likelihood of their 
family members dying in an automobile accident and an average family dying in an 
automobile accident, he or she might assume that his or her own family would only be in 
a car without a seatbelt if they were in a hurry (external explanation), but the average 
family would be in the car without a seatbelt because they were irresponsible (internal 
explanation). This flawed thinking results in an optimistic bias.   
Interestingly, optimistic bias is not a cultural phenomenon; research suggests a 
bias towards unrealistic optimism spans across cultures (Peeters, Cammaert, & 
Czapinski, 1997; Ji, Zhang, Usborne, & Guan, 2004). North Americans, Argentines, and 
Japanese citizens alike reveal an optimistic bias in their perceived risk of experiencing 
natural and manmade disasters (Gierlach, Belsher, & Beutler, 2010). Further, Chang, 
Asakaw, & Sanna (2001) argued that even cultural groups may share a “pessimistic bias” 
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when rating the likelihood of events occurring to other cultural groups. For instance, a 
member of ‘group A’ will likely rate the probability of negative events affecting a 
member of ‘group B’ much higher than the probability of those same negative events 
affecting a member of his own group. Similarly, ‘group B’ participants would probably 
rate a member of ‘group A’ as more likely to experience the negative event than a 
member of her group.   
Given the seemingly pervasive nature of optimistic bias at the individual and 
group level, understanding the perceptions of risk among individuals concerning the 
involvement of themselves or someone they know in an opioid overdose situation is 
central to the current study. 
Gain-Frame/Loss-Frame 
Another way that message designers can manipulate a message is by using a gain-
frame/loss-frame technique. “A positive (gain) frame that emphasizes the advantages of 
compliance, or a negative (loss) frame that emphasizes the disadvantages of 
noncompliance” (O’Keefe & Jensen, 2006, p. 1-2). For example, a gain-frame message 
persuading people not to drink soda would emphasize weight loss and increased energy. 
A loss-frame message would warn people about diabetes and weight-gain.   
In designing messages intended to make audience members consider threats posed 
to their loved ones, messages should emphasize advantages or disadvantages for the 
loved ones resulting in compliance (or lack of compliance) by the reader. For example, a 
campaign targeted at parents encouraging them to set better examples for their children 
by exercising more and inviting their children to join with them could either focus on 
potential gains (healthier children) or potential losses (juvenile diabetes).   
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Not only should message designers be conscious of gain-frame and loss-frame 
techniques, but whether the kernel state of the message is a desirable consequence or an 
undesirable consequence (O’Keefe & Jensen, 2009). A gain-frame message for instance 
can focus on either a desirable consequence or an undesirable consequence. For example, 
an anti-smoking campaign can employ a desirable kernel state such as pretty teeth and 
good hygiene, or an undesirable kernel state such as lung cancer. In a gain-frame 
message, if the undesirable kernel state were chosen, then the gain-frame message would 
emphasize the opportunity to avoid lung cancer by quitting smoking, and the loss-frame 
message would emphasize the consequence of raising one’s lung cancer likelihood by 
continuing to smoke. Therefore, campaign designers have four options to choose from 
(gain/desirable, gain/undesirable, loss/desirable, and loss/undesirable) when creating a 
message.   
One moderating factor that can help message designers determine when to 
employ gain-frame or loss-frame deals with whether the recommendation is prevention or 
detection-related. O’Keefe and Jensen (2006) found that when specifically talking about 
disease, disease prevention messages (i.e., you should eat healthy to avoid obesity) 
should employ gain-frame messages. However, when discussing disease detection (i.e. 
get your colon checked every ten years to screen for cancer), there is no significant 
difference between the two strategies. These framing decisions ultimately impact the 
response that message recipients will have toward the recommended behavior. Prospect 
theory (Tversky & Kahneman, 1981) for example, explains how people respond to risky 
propositions when framed around potential gains as opposed to potential losses. The 
theory suggests that if two equal choices are presented to an individual, one focused on 
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the potential gains and the other focused on the potential losses, the individual is most 
likely to choose the proposal focused on potential gains.   
The relationship between efficacy and framing techniques is not crystal clear. For 
example, while three separate studies all conclude that the effects of framed-messages are 
moderated by self-efficacy, (Van’t Riet, Ruiter, Werrij, & De Vries, 2008; Van’t Riet, 
Ruiter, Werrij, & De Vries, 2010; Werrij, Ruiter, Van’t Riet, & De Vries, 2011), two 
found a loss-frame advantage for those with high perceptions of self-efficacy (Van’t Riet, 
Ruiter, Werrij, & De Vries, 2008; Van’t Riet, Ruiter, Werrij, & De Vries, 2010), and the 
third found a gain-frame advantage (Werrij, Ruiter, Van’t Riet, & De Vries, 2011).   
For the purposes of the current study, the researcher employed an undesirable 
kernel state message in all messages with a gain-frame/loss-frame manipulation. The 
messages focus on the advantages or disadvantages that could be experienced by loved 
ones of the message recipient resulting directly from his compliance or noncompliance to 
the message recommendations. In the context of an opioid overdose, the gain-frame 
message focuses on the message recipient’s loved one recovering from an overdose 
because of the recipient’s compliance to the message recommendation. The loss-frame 
message focuses on the message recipient’s loved one dying because of incompliance to 
the message recommendation. This study aims to identify any differences in reported 
compliance based on which type of message (gain-frame or loss-frame) is randomly 
assigned to each participant. 
 
 
 30 
Labeling and Stigmatization through Language 
The way in which certain message characteristics are framed, such as the names 
given to people or objects, can have a significant impact on the way a message is 
processed (Dillard & Pfau, 2002). One example of this was an experiment that tested two 
versions of descriptive materials to farmers (Menegaki, Mellon, Vrentzou, Koumakis, & 
Tsagarakis, 2009). The farmers that read materials that used the name “recycled water” 
were more likely to use and pay for the irrigation water than the farmers that read 
materials that used the name “treated wastewater.” The clear preference for the term 
“recycled water” is directly related to the stigma attached to the term wastewater.   
Certain words or phrases carry a negative stigma with them that can change the 
way people perceive an issue or individual (Link & Phelan, 2001). For example, referring 
to people living in a country without proper documentation as an “illegal aliens” may 
create more hostility towards that group of people than if they were referred to as 
“undocumented immigrants.” In the medical field, there are many instances of 
terminology with attached negative stigma, including HIV-positive (Vanable, Carey, 
Blair, & Littlewood, 2006), mental illness (Gaebal, Zaske, & Baumann, 2006), and 
obesity (Bombak, McPhail, & Ward, 2016).   
Link and Phelan (2001) provided a five-step explanation of the stigmatization 
through language process that includes labeling, stereotyping, separation, status loss, and 
discrimination. The scholars describe labeling as affixing a name to a person or group of 
people based on an identifiable difference. Scholars in disability discourse first described 
labeling as a driving force of stigmatization by identifying words like “handicapped” and 
“disabled” as potentially harmful (Kailes, 1985; Cortina, 2013). Similarly, the word 
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addict has earned a generally negative connotation (Cortina, 2013), with some calling on 
scholars and professionals to employ a new term when addressing substance use disorder 
patients (Hosea, 2014).   
The lack of effort to challenge the word “addict” has enabled its social acceptance 
in language without consideration to its role in dehumanizing people experiencing 
addiction. In news media, its use by “unbiased” reporters has almost become 
habitual. More concerning, however, is the use of “addict” by professionals who 
advocate against stigma. Although used naively, messages can become confusing 
when elicited stereotypes are incongruent to the larger goal of depicting 
addiction’s humanity (Cortina, 2013, p. 105).   
The current study aims to identify if the label of “addict” has an impact on an 
individual’s perception of susceptibility, severity, and her behavioral intent. The study 
will directly consider the impact of the label “addict” in contrast to the label “victim” to 
understand which is more influential on perceptions and behavioral intentions. 
Linguistic Agency Assignment 
Duranti (2004) defines agency as “the property of entities that have some degree 
of control over their own behavior” (p. 453). McGlone and Pfiester (2009) revealed that 
typically people tend to ascribe agency to themselves in positive situations (i.e., “I did 
well on the test.”). Alternatively, individuals are more likely to ascribe agency to external 
events or forces in negative situations (i.e., “We lost because my teammates let us 
down.”).   
However, when agency is assigned linguistically, an entity is ascribed the ability 
to act or change within the structure of the statement (Bell, McGlone, & Dragojevic, 
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2014). In messages designed to communicate information about health threats, message 
designers can structure statements in one of two ways, by assigning linguistic agency to 
the threat or to the potential victim (McGlone, Bell, Zaitchik, & McGlynn III, 2013). For 
example, McGlynn and McGlone (2018) demonstrated this concept well by assigning 
agency in one message to obesity (Obesity develops in men and women equally) and in 
another message to humans (Men and women are equally likely to grow obese).   
McGlone, Bell, Zaitchik, & McGlynn III (2013) first investigated the effect of 
assigning agency linguistically on behavior change. The researchers gave participants one 
of two versions of a printed educational handout informing them of the dangers of the 
H1N1 virus and the efficacy of the H1N1 vaccine. The first message ascribed agency to 
the virus, and the second message ascribed agency to the reader. The results showed that 
participants who read the message ascribing agency to the virus reported higher 
perceptions of severity and personal susceptibility, as well as a higher intention to get the 
H1N1 vaccination.     
In addition to obesity (McGlynn & McGlone, 2018) and the H1N1 virus 
(McGlone, Bell, Zaitchik, & McGlynn III, 2013), research performed in this area has 
tested linguistic agency assignment with a variety of health threats, including harmful 
bacteria (Bell, McGlone, & Dragojevic, 2014a), HPV (Bell, McGlone, & Dragojevic, 
2014b; Zhang & McGlone, 2018), radon gas (Dragojevic, Bell, & McGlone, 2014), colon 
cancer (Chen, McGlone, & Bell, 2015), diabetes (Glowacki, McGlone, & Bell, 2016), 
cigarette smoking (Wartel, 2017), and depression (Kahn & Peña, 2017).   
Further, individuals may perceive some threats differently than others. For 
example, a message about an external threat, such as a virus or bacteria, might be 
 33 
processed differently than a message with an internal threat, such as obesity or 
depression. Some threats are more easily personified than others as well. For instance, a 
living bacterium may seem more frightening when assigned agency than a wildfire that is 
not a living entity. Opioids may represent a different type of threat altogether. For 
example, one could argue that the pill or the heroin itself is external while addiction is 
internal. 
Table 2 Linguistic Agency Assignment Findings in Health Communication Literature 
Article Threat Relevant Findings 
McGlone, Bell, Zaitchik, 
& McGlynn III, 2013 
H1N1 Threat agency led to higher severity and 
susceptibility perceptions, as well as higher 
behavioral intent.  
Bell, McGlone, & 
Dragojevic, 2014a 
Harmful 
bacteria 
Threat agency led to higher severity and 
susceptibility perceptions. 
Bell, McGlone, & 
Dragojevic, 2014b 
HPV Threat agency led to higher severity 
perception. 
Dragojevic, Bell, & 
McGlone, 2014 
Radon gas Sentient threat agency led to higher severity 
perception. 
Chen, McGlone, & Bell, 
2015 
Colon 
cancer 
Human agency led to higher susceptibility 
perception. 
Glowacki, McGlone, & 
Bell, 2016 
Diabetes Threat agency led to higher severity 
perception. 
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Agency can be assigned linguistically to opioid messages in two ways; Threat 
(opioid) agency and human agency. For example, a threat agency message could state, 
“opioids could kill somebody you love.” A human agency message, on the other hand, 
could say, “somebody you love could die from negligent use of opioids.” In the former 
message, opioids appear to have control over whether they will kill somebody close to 
the message recipient. In that latter message, the recipient’s loved ones seem to have 
control over whether opioids will take their life. These small but important distinctions in 
sentence structure have been shown to have an effect on message recipients’ perceptions 
of threat severity and threat susceptibility (McGlone, Bell, Zaitchik, & McGlynn III, 
2013).  
Hypotheses and Research Question 
EPPM 
In the current study, purchasing and using Narcan is argued to be a highly 
effective behavior for combatting the opioid crisis. The messages created for the current 
study specifically encourage the reader to purchase Narcan. Indirectly, readers may 
experience the need to seek more information about Narcan or to use Narcan in the 
future. Based on the tenets and structure of the EPPM and message design literature, the 
following hypotheses guided analysis of the model.   
H1a: Perception of threat severity, perception of susceptibility, perception of self-
efficacy, and perception of response-efficacy will positively predict the respondents’ 
likelihood to accept the discount coupon for Narcan nasal spray.   
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H1b: Perception of threat severity, perception of susceptibility, perception of self-
efficacy, and perception of response-efficacy will positively predict the respondents’ 
likelihood of seeking more information about Narcan nasal spray.   
H1c: Perception of threat severity, perception of susceptibility, perception of self-
efficacy, and perception of response-efficacy will positively predict the respondents’ 
belief they will own Narcan nasal spray in the future.   
Optimistic bias 
In the current study, respondents’ optimistic bias toward loved ones overdosing 
on opioids is considered. Specifically, the current study measures respondents’ perceived 
likelihood of their loved ones overdosing versus the likelihood of the average person 
overdosing. Based on the optimistic bias scholarship, the following hypotheses are 
posited:   
H2: When considering the likelihood of loved ones overdosing on opioids, respondents 
will display optimistic bias.   
H3a: Optimistic bias concerning loved ones overdosing on opioids will lead to 
significantly lower odds of accepting the discount coupon for Narcan.  
H3b: Optimistic bias concerning loved ones overdosing on opioids will lead to 
significantly lower odds of seeking more information about Narcan.  
H3c: Optimistic bias concerning loved ones overdosing on opioids will lead to 
significantly lower odds of believing that they will own Narcan in the future. 
Gain-frame/loss-frame 
It was suspected that gain-frame messages, or those that emphasize the 
opportunity to save the lives of friends and family by being equipped with Narcan, and 
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loss-frame messages, or those that may emphasize the potential death of friends and 
family if not prepared for an overdose emergency, would result in varying behavioral 
responses. Based on the message design and Prospect Theory literatures, the following 
hypotheses guided the analysis:  
H4a: Self-efficacy will be a stronger predictor of behavioral intent for respondents who 
receive the gain-frame message than those who receive the loss-frame message.   
H4b: Response-efficacy will be a stronger predictor of behavioral intent for respondents 
who receive the gain-frame message than those who receive the loss-frame message.  
Labeling and stigmatization through language 
This study included a linguistic variation on labeling individuals with an opioid 
dependence. The manipulation framed individuals in two different ways: addict or victim. 
Because of the negative effect stigmatized labeling has on message processing 
(Menegaki, Mellon, Vrentzou, Koumakis, & Tsagarakis, 2009), the researcher predicted 
that labeling individuals as addicts will result in a lower likelihood to adhere to message 
recommendations. Therefore, the following hypotheses are offered:   
H5a: The variables of the EPPM (severity, susceptibility, self-efficacy, and response-
efficacy) will be stronger predictors of intention to purchase Narcan in the messages 
labeling people as “victims” rather than “addicts.”  
H5b: The variables of the EPPM (severity, susceptibility, self-efficacy, and response-
efficacy) will be stronger predictors of intention to seek information in the messages 
labeling people as “victims” rather than “addicts.”  
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H5c: The variables of the EPPM (severity, susceptibility, self-efficacy, and response-
efficacy) will be stronger predictors of intention to own Narcan in the messages labeling 
people as “victims” rather than “addicts.”  
Linguistic agency assignment 
Based on the linguistic agency literature that shows perceptions of severity and 
susceptibility are most often higher when reading threat agentic messages, the following 
hypotheses are proposed:    
H6a: Severity will be a stronger predictor of behavioral intention for respondents who 
receive the threat agency message than those who receive the human agency message.   
H6b: Susceptibility will be a stronger predictor of behavioral intention for respondents 
who receive the threat agency message than those who receive the human agency 
message.  
System-efficacy 
Self-efficacy and response-efficacy were included in the original EPPM 
framework, and these variables have received much scholarly attention.  While the 
breadth of literature and empirical data concerning system-efficacy are much smaller, the 
construct of system-efficacy may offer some additional explanative power for the EPPM, 
particularly as individuals consider the greater organizations, entities, or forces at play 
that may affect whether a threat can be overcome. For these reasons, the following 
hypotheses were included to better understand system-efficacy:   
H7: The perception of system-efficacy will positively predict behavioral intent.   
H8a: The perception of system-efficacy will be a better predictor of behavioral intent in 
gain-frame messages than it will be in loss-frame messages.  
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H8b: The perception of system-efficacy will be a better predictor of behavioral intent in 
the “victim” group messages than it will be in the “addict” group messages. 
H8c: The perception of system-efficacy will be a better predictor of behavioral intent in 
threat agentic messages than it will be in human agentic messages. 
Unintended interactions 
Finally, given the breadth of the current study, there may exist some unintended 
main effects or interactions between variables. To identify these instances, the following 
research question is posited:  
RQ1: Do any significant main effects or interactions exist for the three message 
manipulations (gain-frame/loss-frame message manipulation, victim/addict labeling 
manipulation, and linguistic assignment of agency). 
Summary 
This chapter provides an extensive review of existing literature concerning the 
EPPM, optimistic bias, and the message-design elements employed in the study (message 
framing, labeling, and linguistic agency assignment). Based on the hypotheses offered, 
the proposed model for the study is demonstrated visually in figure 4 below. The 
following chapter will detail the research methods of the study in-depth. 
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Figure 4. Proposed Model 
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CHAPTER III  - METHOD 
Participants 
An a priori power analysis using G*Power version 3.1 was first conducted to 
identify the appropriate number of participants. According to the power analysis, 280 
respondents were needed to achieve a 90% power for detecting a small to medium-size 
effect (0.25) when employing the standard .05 criterion for statistical significance 
(Cohen, 1992). Participants were randomly assigned to one of eight message conditions 
(see figure 5). Each message was manipulated according to three independent variables: 
linguistic agency assignment, gain-frame/loss-frame, and stigmatizing “addict”/non-
stigmatizing “victim” labels (Tables 3-5).    
For validation purposes, respondents’ IP addresses were used to screen for 
duplicate individual responses. Additionally, respondents who completed the survey in 
less than 100 seconds were automatically removed from the sample. Finally, one item 
was included to check the respondents’ attention to the survey (e.g., I am paying attention 
to this survey), and three additional items were included to monitor how closely each 
respondent read the message. Participants who did not indicate paying close attention to 
the survey or reading the message were removed from the sample. 
The minimum age of respondents was 18, and they were required to reside within 
the United States at the time of the survey. Participants were recruited through Amazon’s 
online crowdsourcing platform, Amazon Mechanical Turk (MTurk), with a $1.00 
incentive for participating. MTurk has been recognized as an appropriate data collection  
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Figure 5. Message Conditions for Participants 
 
Table 3 Gain-Frame/Loss-Frame Message Conditions 
Gain-Frame Loss-Frame 
You can save them! Your loved ones could be next! 
You can help! The crisis is real… 
NARCAN saves lives NARCAN 
immediately saving their life! he or she will likely die! 
… coupon and save a life! … coupon or you may lose a loved one! 
 
Table 4 Victim/Addict Message Manipulations 
Victim Addict 
Opioids addicts… Victims of the opioid crisis… 
63,000 victims 63,000 addicts 
Who are the victims? Who are the addicts? 
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Table 5 Linguistic Agency Assignment Message Manipulations 
Threat Agency Human Agency 
Opioids are killing people People are dying 
Opioids killed over 63,000 victims 63,000 victims died 
People are overdosing Opioids are killing  
NARCAN restores the victim’s breathing The victim begins breathing 
Opioids suffocate  Victim ingests  
 
tool because of its ability to obtain high-quality and demographically diverse samples 
(Buhrmester, Kwang, & Gosling, 2011; Sheehan, 2017).   
In the early stages of MTurk, scholars questioned the ability of the platform to 
provide a true random sample and valid responses. Primarily, researchers were concerned 
with the data collection technique as survey respondents tend to miss validity checks 
more often and complete surveys more quickly than participants recruited in traditional 
ways (Aruguete et al., 2019). To combat this concern, the current study implemented 
several validity checks and duration timers, as mentioned above, to monitor respondents 
more closely. Second, MTurk respondents are also internet users and may be more 
technologically savvy than the actual population. However, despite this potential 
difference, the ability of crowdsourcing platforms like MTurk to produce a random 
sample of the general population is unmatched by most traditional methods.    
Between March 20, 2019 and March 28, 2019, the researcher gathered 388 
original responses through MTurk. However, not all responses were included in the final 
data set. Using participants’ Internet Protocol (IP) address, the researcher identified 12 
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respondents who completed the survey twice. The twelve duplicate responses were 
removed from the data. 22 surveys were completed in under two minutes, an amount of 
time determined insufficient by the researcher to fully complete the questionnaire, and 
these responses were also omitted from the data. Another 23 surveys were not completed 
fully and were therefore excluded from the data. Finally, 27 participants responded 
unsatisfactorily to attention and reading checks (i.e., they failed to follow basic 
commands created to ensure they were playing close attention to the message and 
survey); these responses were also deleted. After deleting questionable responses, the 
final data set included 304 participants, which was 78.4% of original responses. This 
number exceeded the recommendation of the a priori power analysis by 24.    
Of the 304 participants, 52.6% (n=160) were male, 46.1% (n=140) were female, 
and 1.3% (n=4) reported “other” or did not disclose their biological sex. 78.6% (n=239) 
identified as white, 8.2% (n=25) identified as Black or African American, 7.2% (n=22) 
identified as Asian, 2.3% (n=7) identified as American Indian or Alaska Native, and 
3.6% (n=11) identified as “other.” 15.1% (n=46) of participants identified themselves as 
Hispanic. Sex and racial diversity reflected actual population estimates closely (U.S. 
Census, 2018), suggesting MTurk to be a useful tool for data collection and random 
sampling. Respondents’ ages are reported in table 6. The age group with the most 
participants was 25-34. This happens to be the age group with the largest percentage of 
opioid overdoses from 2017 (Kaiser Family Foundation, 2019).  
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Table 6 Age of Respondents 
Age % (N) 
18 - 24 6.9% (n=24) 
25 - 34 40.7% (n=124) 
35 - 44 29.2% (n=89) 
45 - 54 11.5% (n=35) 
55 - 64 9.2% (n=28) 
65 - 74 2.6% (n=8) 
75 or older 0% (n=0) 
 
Data Collection Procedure 
After respondents agreed to participate in the study, they were presented with 
instructions on the MTurk assignment page. The instructions explained the steps needed 
to complete the survey and receive the incentive while also explaining that duplicate 
responses would not be accepted. A URL led the participants to a survey on the Qualtrics 
website. Once a participant gave informed consent, he or she was randomly assigned to 
one of the eight messages about Narcan nasal spray (see Figure 6 for an example and 
Appendix B for all eight messages). After reading the message, respondents completed 
the accompanying survey questionnaire (Appendix A). After the respondents answered 
all questions, they were instructed to type a code of their choosing into a corresponding 
dialogue box and to also type the same code into the MTurk assignment page. This code 
was used to verify completion of the assignment to provide incentives to participants. 
 45 
 
Figure 6. Message with Victim, Threat Agency, and Gain-Frame Manipulations 
Instruments 
Validity and reliability 
An exploratory factor analysis (EFA) was conducted to assess the validity of the 
scales used in this study. EFA is “a widely utilized and broadly applied statistical 
technique in the social sciences” (Costello & Osborne, 2005, p. 1). EFA assists scholars 
in reducing a set of items into a smaller set of factors, establishing underlying 
dimensions, and providing construct validity for self-reporting scales (Williams, Onsman, 
& Brown, 2010). For the current study, extraction was based on a fixed number of 5 
eigenvalues derived from the theoretical underpinnings of the study variables and 
constructs. A principle components analysis (PCA) was employed with a Varimax 
rotation. Reliability was determined using a Cronbach’s (1951) coefficient alpha to assess 
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the inter-relatedness of the items in each scale. Each variable met the minimally 
acceptable reliability standard of 0.70. 
Measures 
The following section discusses each of the variables used in the study. The 
specific items that correlate with the measures discussed here can be found on the full 
instrument in Appendix A. Results from the EFA and reliability analyses are also found 
in this section. 
Perception of threat severity. Perception of severity was measured using a 
modified version of a three-item scale used by McGlone, Bell, Zaitchik, & McGlynn III, 
(2013) that exhibited high reliability (α=0.82). It was modified to reflect the respondents’ 
perceptions of whether overdosing on opioids may be a threat to friends and family 
members. An additional fourth item was added. Example items for the severity scale 
include “Opioids pose a serious risk my loved ones” and “Opioids are a severe threat to 
my loved ones.” All items were measured by a six-point Likert type scale ranging from 1 
(strongly disagree) to 6 (strongly agree). After reliability analysis, one item was removed 
from the scale to increase the final Cronbach’s alpha. Loadings from the EFA and 
Cronbach’s alpha are reported in table 7. 
Perception of threat susceptibility. Perception of susceptibility was measured 
using a modified version of a three-item scale used by McGlone, Bell, Zaitchik, & 
McGlynn III, (2013) that exhibited high reliability (α=0.81). It was modified to reflect the 
respondents’ perception that their loved ones are susceptible to the opioid crisis. An 
additional fourth item was added. Example items for the susceptibility scale include “It is 
possible that one of my loved ones will overdose on opioids” and “I believe that one of 
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my loved ones could be a victim of the opioid crisis.” All items were subjected to a six-
point Likert type scale ranging from 1 (strongly disagree) to 6 (strongly agree). Loadings 
from the EFA and Cronbach’s alpha are reported in table 8.   
Perception of self-efficacy.  Perception of self-efficacy was measured using a 
modified version of a three-item scale used by McGlone, Bell, Zaitchik, & McGlynn III, 
(2013) that exhibited high reliability (α=0.82). The self-efficacy scale was modified to 
reflect the respondents’ perceptions of whether they have the personal ability to 
successfully use Narcan. An additional fourth item was added. Example items for the 
self-efficacy scale include “Narcan nasal spray is easy to use” and “There is nothing 
preventing me from successfully using Narcan nasal spray.” All items were subjected to a 
six-point Likert type scale ranging from 1 (strongly disagree) to 6 (strongly agree). After 
reliability analysis, one item was removed from the scale in order to increase the final 
Cronbach’s alpha. Loadings from the EFA and Cronbach’s alpha are reported in table 9.   
Perception of response-efficacy. Perception of response-efficacy was measured 
using a modified version of a three-item scale used by McGlone, Bell, Zaitchik, & 
McGlynn III, (2013) that exhibited high reliability (α=0.77). The response-efficacy scale 
was modified to reflect the respondents’ perceptions of whether Narcan is believed to be 
an effective remedy for opioid overdose experiences. An additional fourth item was 
added. Example items for the response-efficacy scale include “Narcan nasal spray will 
prevent the death of a loved one who has overdosed” and “Narcan nasal spray is effective 
in ending the threat of a friend or family member dying from an overdose.” All items 
were subjected to a six-point Likert type scale ranging from 1 (strongly disagree) to 6 
(strongly agree). Loadings from the EFA and Cronbach’s alpha are reported in table 10.   
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Perception of system-efficacy. A four-item scale was created to measure system-
efficacy. The system-efficacy scale was built to reflect the respondents’ perceptions of 
how well the system that they belong to protects their loved ones from the opioid crisis. 
Example items for the system-efficacy scale include “I believe there are organizations or 
agencies that want to protect me from the opioid crisis” and “Pharmaceutical researchers 
and scientists want to protect me from the opioid crisis.” All items were subjected to a 
six-point Likert type scale ranging from 1 (strongly disagree) to 6 (strongly agree). 
Loadings from the EFA and Cronbach’s alpha are reported in table 11.   
Table 7 Validity and Reliability for Perception of Threat Severity Scale 
Item EFA Factor 
Loading 
Opioids pose a serious risk to my loved ones. 0.52 
Opioids are potentially harmful to my loved ones.  0.66 
Opioids are a severe threat to my loved ones.  0.61 
Note: Cronbach’s alpha was 0.91 
Table 8 Validity and Reliability for Perception of Threat Susceptibility Scale 
Item EFA Factor 
Loading 
My loved ones are at risk for being an opioid overdose victim. 0.89 
It is possible that one of my loved ones will overdose on opioids.  0.91 
I believe that one of my loved ones could be a victim of the opioid crisis.  0.92 
An opioid overdose could happen to one of my loved ones.   0.91 
Note: Cronbach’s alpha was 0.95 
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Table 9 Validity and Reliability for Perception of Self-Efficacy Scale 
Item EFA 
Factor 
Loading 
Narcan nasal spray is easy to use 0.68 
There is nothing preventing me from successfully using Narcan nasal spray.  0.85 
I have the ability to use Narcan nasal spray if required.    0.83 
Note: Cronbach’s alpha was 0.82 
Table 10 Validity and Reliability for Perception of Response-Efficacy Scale 
Item EFA 
Factor 
Loading 
Narcan nasal spray will prevent the death of a loved one who has 
overdosed. 
0.73 
My loved ones are less likely to die from an overdose if I have Narcan nasal 
spray.  
0.77 
Narcan nasal spray is effective in ending the threat of a loved one dying 
from an overdose. 
0.79 
If someone has overdosed on opioids, I believe Narcan nasal spray can save 
them.     
0.83 
Note: Cronbach’s alpha was 0.83 
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Table 11 Validity and Reliability for Perception of System-Efficacy Scale 
Item EFA 
Factor 
Loading 
I believe there are organizations or agencies that want to protect me from 
the opioid crisis. 
0.40 
The government will help me respond to the opioid crisis. 0.79 
My friends and family will protect me from the opioid crisis. 0.76 
Pharmaceutical researchers and scientists want to protect me from the 
opioid crisis.     
0.68 
Note: Cronbach’s alpha was 0.73 
Optimistic bias. In order to calculate an individual score for optimistic bias, this 
study followed a three-step process. First, respondents were asked “What are the odds 
that one of your loved ones will overdose on opioids or heroin?” Answers were collected 
on an 11-point scale ranging from “0 = not likely at all” to “10 = extremely likely.” 
Second, respondents were asked “What are the odds that the average person will 
overdose on opioids or heroin?” The same 11-point scale was used. Finally, the 
difference between the two scores was used for each respondent, representing their 
optimistic bias score. 
Accept Code. Respondents were asked if they would like a 75% off coupon for 
Narcan nasal spray at the end of the survey. Their response to this offer (‘yes’ or ‘no’) 
was used as a dependent measure of behavioral intent.  
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Intent to Own. A second measure of behavioral intent, respondents were also 
asked if they think they will ever own Narcan nasal spray in the future. The difference 
between this dependent variable and the dependent variable “Accept Code”, is urgency. 
Those who wish to purchase now, or soon, will be more likely to accept the discount 
code. Those who intend to purchase, but not necessarily in the near future, may indicate 
intent to own but refuse the discount offer.  
Intent to Seek Information. Finally, for a third behavioral intent dependent 
variable, participants were asked if they plan on seeking more information about opioids 
or Narcan nasal spray. Their response to this item, “Accept Code”, and “Intent to Own” 
were used to measure behavioral intent. The three items were used independently from 
each other in the analysis.  
Correlates. A series of items were used to measure anticipated extraneous 
variables. These items included “Have you ever owned Narcan nasal spray?”, “Have you 
ever used Narcan nasal spray?”, “Has someone close to you ever overdosed on opioids or 
heroin?", “Before taking this survey, did you know what Narcan nasal spray was?", and 
“How familiar were you with Narcan nasal spray prior to taking this survey?” 
Table 12 Means and Standard Deviations of Variables and Correlates 
Item M SD 
Optimistic Bias 1.41 2.51 
Perception of Severity 3.80 1.41 
Perception of Susceptibility 3.49 1.43 
Perception of Self-Efficacy 4.67 0.95 
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Table 12 Continued 
Perception of Response-efficacy 4.72 0.87 
Perception of System-efficacy 4.11 0.94 
Accept Discount Code 0.32 0.47 
Belief of Owning Narcan Nasal Spray in the Future 2.13 0.88 
Intention to Seek Information (Yes or No) 0.41 0.49 
Intention to Seek Information (Likelihood Scale) 3.75 2.12 
Has Owned Narcan Before 1.46 0.93 
Has Used Narcan Before 1.48 0.93 
Has Experienced Someone Close Overdose 1.82 1.23 
Has Prior Knowledge about Narcan     2.53 1.28 
Is Familiar with Narcan 2.43 1.34 
 
Data Analysis 
Missing data 
Because of the small frequency of missing data, mean imputation was employed 
to replace the missing values. This technique is frequently used (Batista & Monard, 
2003), and mean imputation often performs better than other methods such as multiple 
imputation and random selection (Shrive, Stuart, Quan, & Ghali, 2006) because of its 
“attractive balance of both accuracy and conceptual simplicity” (p. 9). 
Assumptions 
The standard skewness value of ±2, and the standard kurtosis value of ±3 were 
not met for any of the variables tested (Field, 2013). However, in datasets with large 
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sample sizes, violating normality has a very small and often insignificant impact on the 
analysis (Tabachnick & Fidell, 2012; Joanes & Gill, 1998). KMO and Bartlett’s Test of 
Sphericity revealed a KMO score of .883 while the Bartlett’s Test of Sphericity was 
significant (p<.001). The high KMO value indicated that the sample was adequate, and 
the significance of Bartlett’s Test of Sphericity revealed that the assumption of sphericity 
was met. Finally, assumptions of linearity were tested by graphing the relationships 
among relevant study variables, revealing appropriate linear relationships. The 
assumption of multicollinearity was met as all tolerance values were above the standard 
of 0.2 (Field, 2013). 
Table 13 Collinearity Statistics 
Item Tolerance VIF 
Optimistic Bias .786 1.27 
Perception of Severity .398 2.51 
Perception of Susceptibility .363 2.75 
Perception of Self-Efficacy .784 1.28 
Perception of Response-efficacy .669 1.50 
Perception of System-efficacy .716 1.40 
 
Structural Equation Modeling 
Using AMOS 24.0, SEM was conducted to address the hypotheses and research 
questions. SEM is “a statistical methodology that takes a confirmatory (i.e., hypothesis-
testing) approach to the analysis of a structural theory bearing on some phenomenon” 
(Byrne, 2016, p. 3). Typically, SEM includes the items for each structure in the model. In 
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this study, an EFA was conducted prior to building the model, and the resulting 
constructs were employed. Byrne (2016) argues SEM accomplishes four tasks that 
separate it from other multivariate procedures. First, its confirmatory approach provides 
better inferential analysis that makes hypothesis testing easier. Second, SEM provides 
explicit estimates of error that minimize inaccuracies. Third, SEM can incorporate 
unobserved or latent variables within a model. Fourth, SEM easily models multivariate 
relations.  
Once the proposed model (figure 4) was constructed, several fit-indices measured 
how well the data fit the model. Normal fit index (NFI) indicates the fit relative to the 
null model (Kenny, 2015) Comparative fit index (CFI) is not sensitive to sample size and 
compares the fit of the target model to the fit of an independent model (Kenny, 2015). 
Incremental fit index (IFI) is analogous to R2 (Kenny, 2015). Finally, the root-mean 
square error of approximation (RMSEA) was used, as it is an absolute measure of fit 
dependent on the non-centrality parameter (Kenny, 2015).   
In the proposed model, optimistic bias, severity, and susceptibility were covaried 
because of their theoretical relationship to threat perception. Self-efficacy, response-
efficacy, and system-efficacy were also covaried because of their theoretical relationship 
with to efficacy perception. The proposed model also controlled for all demographics, 
including age, sex, ethnicity, and gender. Each of the demographics were covaried with 
one another. Finally, the five correlates, including one’s familiarity with Narcan, whether 
an individual has owned Narcan, whether an individual has used Narcan, whether he or 
she has prior knowledge of Narcan, and whether he or she has experience with an 
overdose event were controlled for and covaried to one another. The fit indices for the 
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proposed model are shown in table 14, with the covariance estimates in table 15, and the 
regression weights in table 16. 
Table 14 Fit Indices for the Proposed Model 
Index Result 
NFI .875 
IFI .915 
CFI .912 
RMSEA .077 
 
Table 15 Covariance Estimates for the Proposed Model 
Variables Estimate S.E. C.R. p 
Age2534 <--> Age1824 -.028 .007 -3.828 <.001* 
Age1824 <--> Age3544 -.020 .007 -2.998 .003* 
Age1824 <--> Age4554 -.008 .005 -1.699 .089 
Age1824 <--> Age5564 -.006 .004 -1.502 .133 
Age2534 <--> Age3544 -.119 .015 -8.181 <.001* 
Age2534 <--> Age4554 -.047 .009 -4.979 <.001* 
Age2534 <--> Age5564 -.037 .008 -4.437 <.001* 
Age3544 <--> Age4554 -.033 .009 -3.926 <.001* 
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Table 15 Continued 
Age3544 <--> Age5564 -.027 .008 -3.486 <.001* 
Age4554 <--> Age5564 -.011 .005 -1.983 .047* 
Female <--> Hispanic .000 .010 -.006 .995 
Female <--> Black .015 .008 1.881 .060 
Female <--> Asian .000 .007 -.044 .965 
Female <--> White .003 .012 .234 .815 
Hispanic <--> Black .017 .006 2.982 .003* 
Hispanic <--> Asian -.004 .005 -.834 .404 
Hispanic <--> White -.033 .009 -3.846 <.001* 
Black <--> Asian -.006 .004 -1.448 .148 
Black <--> White -.064 .007 -8.682 <.001* 
Asian <--> White -.057 .007 -8.234 <.001* 
Age1824 <--> Female .001 .007 .163 .870 
Age1824 <--> Hispanic .003 .005 .506 .613 
Age1824 <--> Black -.002 .004 -.593 .553 
Age1824 <--> Asian .008 .004 2.152 .031* 
Age1824 <--> White -.002 .006 -.289 .772 
Age2534 <--> Female -.052 .014 -3.636 <.001* 
Age2534 <--> Hispanic .020 .010 1.977 .048* 
Age2534 <--> Black .003 .008 .355 .723 
Age2534 <--> Asian .003 .007 .475 .635 
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Table 15 Continued 
Age2534 <--> White -.022 .012 -1.858 .063 
Age3544 <--> Female .017 .013 1.295 .195 
Age3544 <--> Hispanic .002 .009 .263 .792 
Age3544 <--> Black .006 .007 .781 .435 
Age3544 <--> Asian -.001 .007 -.204 .838 
Age3544 <--> White .000 .011 -.010 .992 
Age4554 <--> Female .016 .009 1.767 .077 
Age4554 <--> Hispanic -.014 .007 -2.156 .031* 
Age4554 <--> Black .000 .005 .086 .932 
Age4554 <--> Asian -.002 .005 -.364 .716 
Age4554 <--> White .002 .007 .201 .841 
Age5564 <--> Female .010 .008 1.247 .212 
Age5564 <--> Hispanic -.007 .006 -1.167 .243 
Age5564 <--> Black -.004 .005 -.933 .351 
Age5564 <--> Asian -.007 .004 -1.540 .124 
Age5564 <--> White .016 .007 2.379 .017* 
OptimisticBias <--> Susceptibility -1.526 .223 -6.854 <.001* 
SelfEfficacy <--> SystemEfficacy .209 .053 3.962 <.001* 
PriorKnowledge <--> Familiarity 1.284 .122 10.481 <.001* 
Familiarity <--> Experienced .483 .087 5.544 <.001* 
Familiarity <--> EverUsed .518 .077 6.711 <.001* 
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Table 15 Continued 
Familiarity <--> EverOwned .491 .076 6.433 <.001* 
PriorKnowledge <--> Experienced .357 .081 4.384 <.001* 
PriorKnowledge <--> EverUsed .217 .069 3.138 .002* 
PriorKnowledge <--> EverOwned .233 .069 3.375 <.001* 
Experienced <--> EverUsed .376 .061 6.134 <.001* 
Experienced <--> EverOwned .426 .062 6.851 <.001* 
EverUsed <--> EverOwned .712 .064 11.109 <.001* 
SelfEfficacy <--> ResponseEfficacy .382 .052 7.298 <.001* 
SystemEfficacy <--> ResponseEfficacy .359 .051 6.991 <.001* 
OptimisticBias <--> Severity -.954 .210 -4.549 <.001* 
Susceptibility <--> Severity 1.529 .145 10.571 <.001* 
 
Table 16 Regression Weights for the Proposed Model 
Path Estimate S.E. C.R. p 
System-efficacy → Intent to Seek .271 .121 2.236 .025* 
System-efficacy → Accept Code .041 .027 1.531 .126 
System-efficacy → Intent to Own -.058 .044 -1.318 .187 
Response-efficacy → Intent to Seek .018 .143 .128 .898 
Response-efficacy → Accept Code -.004 .032 -.127 .899 
Response-efficacy → Intent to Own .110 .052 2.103 .035* 
Self-efficacy → Intent to Seek -.012 .122 -.097 .922 
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Table 16 Continued 
Self-efficacy → Accept Code -.013 .027 -.483 .629 
Self-efficacy → Intent to Own .062 .044 1.398 .162 
Susceptibility → Intent to Seek .388 .119 3.257 .001* 
Susceptibility → Accept Code .052 .026 1.988 .047* 
Susceptibility → Intent to Own .157 .044 3.604 <.001* 
Severity → Intent to Seek .237 .113 2.094 .036* 
Severity → Accept Code -.018 .025 -.702 .483 
Severity → Intent to Own -.004 .041 -.106 .916 
Optimistic Bias → Intent to Seek -.038 .045 -.835 .404 
Optimistic Bias → Accept Code .006 .010 .564 .572 
Optimistic Bias → Intent to Own .013 .017 .756 .450 
Familiarity → Intent to Seek .125 .130 .966 .334 
Familiarity → Accept Code .042 .029 1.455 .146 
Familiarity → Intent to Own .071 .047 1.505 .132 
Prior Knowledge → Intent to Seek -.134 .125 -1.071 .284 
Prior Knowledge → Accept Code -.022 .028 -.778 .437 
Prior Knowledge → Intent to Own .009 .046 .201 .841 
Overdose Experience → Intent to Seek -.078 .108 -.724 .469 
Overdose Experience → Accept Code .032 .024 1.340 .180 
Overdose Experience → Intent to Own .059 .039 1.509 .131 
Ever Used → Intent to Seek .046 .201 .229 .819 
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Table 16 Continued 
Ever Used → Accept Code .125 .044 2.827 .005* 
Ever Used → Intent to Own .074 .073 1.005 .315 
Ever Owned → Intent to Seek .234 .202 1.160 .246 
Ever Owned → Accept Code .043 .045 .961 .337 
Ever Owned → Intent to Own .340 .074 4.596 <.001* 
White → Intent to Seek .117 .461 .253 .800 
White → Accept Code .083 .102 .818 .413 
White → Intent to Own .043 .169 .254 .800 
Asian → Intent to Seek .229 .592 .388 .698 
Asian → Accept Code .175 .131 1.335 .182 
Asian → Intent to Own .106 .216 .491 .623 
Black → Intent to Seek .721 .565 1.275 .202 
Black → Accept Code .117 .125 .936 .349 
Black → Intent to Own .009 .207 .042 .967 
Hispanic → Intent to Seek -.037 .306 -.119 .905 
Hispanic → Accept Code .076 .068 1.125 .261 
Hispanic → Intent to Own -.029 .112 -.260 .795 
Female → Intent to Seek .314 .215 1.462 .144 
Female → Accept Code .067 .047 1.419 .156 
Female → Intent to Own .207 .078 2.642 .008* 
Age 55-64 → Intent to Seek .249 .719 .346 .729 
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Table 16 Continued 
Age 55-64 → Accept Code -.080 .159 -.501 .617 
Age 55-64 → Intent to Own -.212 .263 -.808 .419 
Age 45-54 → Intent to Seek -.046 .704 -.065 .948 
Age 45-54 → Accept Code -.275 .155 -1.768 .077 
Age 45-54 → Intent to Own -.225 .257 -.873 .383 
Age 35-44 → Intent to Seek .071 .666 .107 .915 
Age 35-44 → Accept Code -.203 .147 -1.380 .167 
Age 35-44 → Intent to Own -.113 .244 -.466 .641 
Age 18-24 → Intent to Seek -.132 .275 -.478 .633 
Age 18-24 → Accept Code -.343 .166 -2.060 .039* 
Age 18-24 → Intent to Own -.345 .753 -.458 .647 
Age 25-34 → Intent to Seek -.100 .243 -.412 .680 
Age 25-34 → Accept Code -.179 .147 -1.223 .221 
Age 25-34 → Intent to Own -.134 .665 -.201 .840 
 
Once the proposed model was tested, the researcher adjusted the model by 
following the modification indices, covariance estimates, and regression weights. 
Optimistic bias was removed from the model because it was not a predictor of any 
behavioral intent variable and because the model fit increased upon its removal. Kenny 
(2011) suggests that this type of model trimming is appropriate if there is theoretical 
justification for doing so. Because optimistic bias is not a theoretical construct of the 
EPPM, its exclusion was validated. Similarly, all demographic controls with the 
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exception of gender were removed from the model as they were not significant predictors 
of behavioral intent. Their removal increased the model fit. Three of the five correlates 
were also removed from the model, including prior knowledge, experience with an 
overdose event, and prior use. These were removed because of their inability to predict 
behavioral intent 
The SEM modification indices recommended covarying the following sets of 
variables that were not originally covaried: 1) Severity and Ever Owned, 2) Severity and 
System-Efficacy, 3) Susceptibility and Ever Owned, 4) Susceptibility and System-
Efficacy, and 5) System-Efficacy and Ever Owned. The remaining pairs of variables that 
were covaried in the proposed model remained significant and covaried in the final model 
(shown in figure 7). Fit indices (see table 17) covariance estimates (see table 18) and 
maximum likelihood estimates (see table 19) are reported. All fit indices indicated the 
data fit the model as the NFI, IFI, and CFI were all above .95 and the RMSEA was below 
.06 (Hooper, Coughlan, & Mullen, 2008).   
The researcher created six groups corresponding to the model to test the 
hypotheses. These groups include a gain-frame group, a loss-frame group, a threat agency 
group, a human agency group, a victim label group, and an addict label group. Estimates 
within each group were compared to the corresponding groups based on the hypotheses.  
To conclude chapter three, this study was designed to test messages intended to persuade 
respondents to purchase Narcan nasal spray using the EPPM as a theoretical framework. 
The resulting survey data were used to address the study’s guiding hypotheses and 
research question. These results are found in chapter four, and implications are discussed 
further in chapter five. 
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Table 17 Fit Indices for Final Model  
Index Result 
NFI .954 
IFI .982 
CFI .982 
RMSEA .044 
 
Table 18 Covariance Estimates for the Final Model 
Variables  Estimate  S.E.  C.R.  p  
Severity <--> Susceptibility  1.529  .145  10.57  <.001*  
Severity <--> System-efficacy  .358  .070  5.028  <.001*  
Severity <--> Ever Owned  .255  .070  3.627  <.001*  
Susceptibility <--> System-efficacy  
Susceptibility <--> Ever Owned  
.286  
.378  
.071  
.073  
4.028 
5.175  
<.001*  
<.001*  
Self-Efficacy <--> System-efficacy  .194  .049  3.947  <.001*  
Self-Efficacy <--> Response-efficacy  .382  .052  7.298  <.001*  
Response-efficacy <--> System-efficacy  .349  .048  7.237  <.001*  
System-efficacy <--> Ever Owned  .207  .043  4.816  <.001*  
Ever Owned <--> Familiarity  .402  .068  5.865  <.001*  
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Figure 7. Final Model 
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CHAPTER IV – ANALYSIS 
Chapter IV begins with analyses addressing the hypotheses posited in chapter II, 
followed by analysis responding to RQ1. The sections in this chapter correlate to each 
hypothesis and research question. 
Hypothesis Testing 
Hypothesis 1a 
Hypothesis 1a stated that perception of 1.) severity, 2.) susceptibility, 3.) self-
efficacy, and 4.) response-efficacy would positively predict the respondents’ likelihood to 
accept the discount coupon code for Narcan nasal spray. This hypothesis was only 
partially supported because not all variables were significant predictors of participants 
accepting the code. Specifically, severity, self-efficacy, and response-efficacy did not 
significantly predict coupon code acceptance. However, susceptibility was a significant 
predictor of code acceptance in the overall model (β = 0.06, SE = 0.02, p <.001). Twenty 
percent of the variance is accounted for by susceptibility (R2=0.20). Specifically, for 
every increase of a unit of susceptibility, there was a 0.064 unit increase in participants’ 
code acceptance. Therefore, of the four EPPM predicting variables, only high perceptions 
of susceptibility predicted discount code acceptance.   
Hypothesis 1b 
Hypothesis 1b stated that perception of 1.) severity, 2.) susceptibility, 3.) self-
efficacy, and 4.) response-efficacy would positively predict the respondents’ likelihood of 
seeking more information about Narcan nasal spray. This hypothesis was also only 
partially supported. Both severity (β = 0.25, SE = 0.10, p=.014) and susceptibility (β = 
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0.46, SE = 0.11, p < .001) significantly predicted intent to seek more information; neither 
self-efficacy nor response-efficacy significantly predicted the intent to seek more 
information. Twenty-six percent of the variance was explained by susceptibility and 
severity (R2=0.26). For every unit increase in perceived severity, there was a 0.25 unit 
increase in one’s intent to seek information. Similarly, for every unit increase in 
susceptibility, there was a 0.46 unit increase in intent to seek information. Therefore, a 
high threat perception predicted intent to seek more information and a high efficacy 
perception did not.   
Hypothesis 1c 
Hypothesis 1c stated that, perception of 1.) severity, 2.) susceptibility, 3.) self-
efficacy, and 4.) response-efficacy would positively predict the respondents’ belief they 
will own Narcan nasal spray in the future. This hypothesis was also only partially 
supported as two of the four variables were not significant predictors. Specifically, 
susceptibility (β = 0.17, SE = 0.03, p<.001) and response-efficacy (β = 0.13, SE = 0.04, 
p<.001) were significant predictors of one’s intent to own Narcan, while severity and 
self-efficacy were not significant predictors. Thirty-eight percent of the variance was 
explained by susceptibility and response-efficacy (R2=0.38). For every unit increase in 
perceived susceptibility, there was a 0.17 unit increase in one’s intent to own. For every 
unit increase in response-efficacy, there was a 0.13 unit increase in intent to own.  
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Table 19 SEM Final Model Maximum Likelihood Estimates 
Path  Estimate  S.E.  C.R.  p  
     Susceptibility → Accept Code  .064  .017  3.650  <.001*  
     System-efficacy → Accept Code  .053  .024  2.214  .027*  
     Ever Owned → Accept Code  .149  .026  5.859  <.001*  
     Severity → Intent to Seek  .251  .102  2.460  .014*  
     Susceptibility → Intent to Seek  .461  .105  4.367  <.001*  
     System-efficacy → Intent to Seek  .355  .107  3.311  <.001*  
     Susceptibility → Intent to Own  .173  .028  6.224  <.001*  
     Response-efficacy → Intent to Own  .133  .038  3.479  <.001*  
     Female → Intent to Own  .132  .065  2.030  .042*  
     Ever Owned → Intent to Own  .376  .042  8.886  <.001*  
     Familiarity → Intent to Own  .062 .026 2.393 .017* 
 
Hypothesis 2 
Hypothesis 2 stated that when considering the likelihood of loved ones 
overdosing on opioids, respondents will display optimistic bias. This hypothesis was 
supported as there was a significant difference (t=9.808, p<.001, d=0.54) between the 
perceived likelihood of loved ones overdosing (M=3.93, SD=2.84) and the perceived 
likelihood of external others overdosing (M=5.34, SD=2.40). The results indicate a 
medium effect size according to Cohen’s (1992) suggested standards.   
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Hypothesis 3a 
Because the variable optimistic bias was removed from the overall model, a 
separate regression analysis was conducted for hypotheses 3a-3c. Hypothesis 3a stated 
that optimistic bias concerning loved ones overdosing on opioids would lead to 
significantly lower odds of respondents accepting the discount coupon for Narcan. This 
hypothesis was supported as the model was significant (F(1,303)=7.141, p<.008, R2=.02). 
Optimistic bias was a significant predictor of accepting the discount coupon (β=-.028, 
p=.008). Specifically, for every unit of optimistic bias, a participant was .028 units less 
likely to accept the code.   
Hypothesis 3b 
Hypothesis 3b stated that optimistic bias concerning loved ones overdosing on 
opioids would lead to significantly lower odds of seeking more information about 
Narcan. This hypothesis was supported (F(4,300)=11.759, p < .001, R2=.14). Optimistic 
bias was a significant predictor of a person’s intent to seek information (β=-.132, 
p=.006). Specifically, for every unit increase in optimistic bias, there was a 0.132 unit 
decrease in intent to seek information concerning Narcan. Additionally, previous 
ownership of Narcan (β=.567, p<.001) significantly increased one’s intent to seek 
information by 0.567 units. Certain demographic characteristics were also more 
significant predictors than others. For instance, being African American (β=.962, p=.022) 
significantly increased one’s intent to seek information by 0.962 units. Being female 
(β=.563, p=.016) significantly increased intent to seek by 0.563 units.   
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Hypothesis 3c 
Hypothesis 3c stated that optimistic bias concerning loved ones overdosing on 
opioids would lead to significantly lower odds of respondents believing they will own 
Narcan in the future. This hypothesis was supported as the model was significant 
(F(1,303)=15.213, p<.001, R2=.05). Optimistic bias was a significant predictor of 
respondent’s belief that they will own Narcan in the future (β=-.077, p <.001). 
Specifically, for every unit increase in optimistic bias, there is a 0.077 unit decrease in 
intent to own Narcan. 
Hypothesis 4a 
Hypothesis 4a stated that self-efficacy would be a stronger predictor of behavioral 
intent for respondents receiving the gain-frame message than those receiving the loss-
frame message. Self-efficacy was not a significant predictor in either the gain-frame 
group or the loss-frame group. Therefore, to distinguish between the groups, an 
independent samples t-test was conducted. The test was not significant (t=1.207, p=.228) 
as the gain-frame group (M=4.74, SD=0.96) did not lead to significantly higher self-
efficacy scores than the loss frame group (M=4.60, SD=0.94). As a result, hypothesis 4a 
was not supported. 
Hypothesis 4b 
Hypothesis 4b stated that response-efficacy would be a stronger predictor of 
behavioral intent for respondents receiving the gain-frame message over those receiving 
the loss-frame message. Response-efficacy was only a predictor of one behavioral intent 
variable (intent to own Narcan nasal spray in the future). The hypothesis was not 
supported. In fact, the opposite of what was predicted occurred. Response-efficacy was a 
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predictor of intent to own in the loss-frame group (β = 0.64, SE = 0.06, p = .005, 
R2=0.39), but not in the gain-frame group (β = 0.91, SE = 0.05, p = .077, R2=0.37). The 
results for gain-frame and loss-frame groups are presented in table 20. 
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Table 20 Gain-Frame and Loss-Frame Group Results 
Path  Estimate  S.E.  C.R.  p  
Gain-Frame          
     Susceptibility →Accept Code  .041 .023 1.792 .073 
     System-efficacy →Accept Code  .035 .032 1.095 .273 
     Ever Owned →Accept Code  .211 .032 6.527 <.001* 
     Severity →Intent to Seek  .195 .149 1.313 .189 
     Susceptibility → Intent to Seek  .333 .154 2.161 .031* 
     System-efficacy → Intent to Seek  .441 .141 3.123 .002* 
     Susceptibility → Intent to Own  .157 .037 4.288 <.001* 
     Response-efficacy → Intent to Own  .091 .051 1.769 .077 
     Ever Owned → Intent to Own  .344 .053 6.558 <.001* 
     Familiarity → Intent to Own .089 .036 2.506 .012* 
     Female → Intent to Own .093 .085 1.093 .274 
Loss-Frame      
     Susceptibility → Accept Code  .094 .026 3.589 <.001* 
     System-efficacy → Accept Code  .064 .036 1.796 .072 
     Ever Owned → Accept Code  .075 .040 1.869 .062 
     Severity → Intent to Seek  .332 .136 2.444 .015* 
     Susceptibility → Intent to Seek  .570 .142 4.027 <.001* 
     System-efficacy → Intent to Seek  .317 .158 2.011 .044* 
     Susceptibility → Intent to Own  .193 .043 4.527 <.001* 
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Table 20 Continued 
     Response-efficacy → Intent to Own  .160 .056 2.835 .005* 
     Ever Owned → Intent to Own  .401 .069 5.847 <.001* 
     Familiarity → Intent to Own .048 .037 1.297 .195 
     Female → Intent to Own .150 .098 1.538 .274 
 
Hypothesis 5a 
Hypothesis 5a stated that the variables of the EPPM (severity, susceptibility, self-
efficacy, and response-efficacy) would be stronger predictors of intent to accept the 
discount code for Narcan in the messages labeling people as “victims” rather than 
“addicts.” Because susceptibility was the only EPPM variable that significantly predicted 
Narcan code acceptance in the overall model, it was the only variable tested in this 
hypothesis. Regardless, the hypothesis was not supported; when comparing the regression 
weights for the two groups, the results were nearly the same for the victim label (β = 
0.06, SE = 0.02, p=.010, R2=0.15) as they were for the addict label (β = 0.07, SE = 0.03, 
p=.008, R2=0.24).   
Hypothesis 5b  
Hypothesis 5b stated that the variables of the EPPM (severity, susceptibility, self-
efficacy, and response-efficacy) would be stronger predictors of intent to seek 
information in the messages labeling people as “victims” over messages labeling them 
“addicts.” Because severity and susceptibility were the only EPPM variables that 
significantly predicted intent to seek in the overall model, they were the only variables 
tested for this hypothesis. Regarding severity, the hypothesis was supported. Severity was 
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a significant predictor of intent to seek more information in the message labeling people 
“victims” (β = 0.30, SE = 0.15, p=.036, R2=0.28) and was not a predictor in the message 
labeling people “addicts” (β = 0.20, SE = 0.14, p=.172, R2=0.25). With susceptibility, the 
hypothesis was not supported. Although the regression weights were very close between 
the two groups, susceptibility was a better predictor in the addict message (β = 0.46, SE = 
0.14, p=.001, R2=0.25) than it was the victim message (β = 0.45, SE = 0.16, p=.004, 
R2=0.28). However, the differences are too small to interpret anything meaningful from 
this finding. Therefore, the hypothesis was only supported regarding the perception of 
severity. 
Hypothesis 5c 
Hypothesis 5c stated that the variables of the EPPM (severity, susceptibility, self-
efficacy, and response-efficacy) would be stronger predictors of intent to own Narcan in 
the messages labeling people as “victims” rather than “addicts.” This time, only 
susceptibility and response-efficacy were employed to test the hypothesis because they 
were the only significant predictors of intent to own Narcan in the overall model. 
Susceptibility was a significant predictor of intent to own Narcan regardless of how 
people were labeled. The estimate was slightly higher, albeit not in a statistically 
meaningful way, in the “addict”-labeled message (β = 0.17, SE = 0.04, p<.001, R2=0.42) 
than it was the “victim”-labeled message (β = 0.17, SE = 0.04, p<.001, R2=0.33).  
For response-efficacy, there was a significant difference between labels, but 
opposite to what was predicted. Response-efficacy was a significant predictor of intent to 
own Narcan in the group receiving the “addict” message (β = 0.18, SE = 0.05, p<.001, 
R2=0.42), but response-efficacy was not a predictor in the group receiving the “victim” 
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message (β = 0.08, SE = 0.05, p=.152, R2=0.33). Therefore, the hypothesis was not 
supported, but the finding for response-efficacy was meaningful. The results of the 
victim/addict labeling models are included in table 21. 
Table 21 Victim Label and Addict Label Group Results 
Path  Estimate  S.E.  C.R.  p  
Victim Label          
     Susceptibility →Accept Code  .061 .024 2.568 .010* 
     System-efficacy →Accept Code  .056 .032 1.786 .074 
     Ever Owned →Accept Code  .117 .037 3.142 .002* 
     Severity →Intent to Seek  .303 .145 2.098 .036* 
     Susceptibility → Intent to Seek  .447 .155 2.878 .004* 
     System-efficacy → Intent to Seek  .305 .149 2.043 .041* 
     Susceptibility → Intent to Own  .166 .040 4.147 <.001* 
     Response-efficacy → Intent to Own  .078 .054 1.432 .152 
     Ever Owned → Intent to Own  .418 .065 6.470 <.001* 
     Familiarity → Intent to Own .026 .037 0.700 .484 
     Female → Intent to Own .052 .091 0.573 .567 
Addict Label 
    
     Susceptibility → Accept Code  .067 .025 2.652 .008* 
     System-efficacy → Accept Code  .049 .036 1.362 .173 
     Ever Owned → Accept Code  .172 .035 4.859 <.001* 
     Severity → Intent to Seek  .196 .143 1.366 .172 
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Table 21 Continued 
     Susceptibility → Intent to Seek  .464 .143 3.253 .001* 
     System-efficacy → Intent to Seek  .412 .152 2.722 .006* 
     Susceptibility → Intent to Own  .168 .039  4.319 <.001* 
     Response-efficacy → Intent to Own .183 .053 3.458 <.001* 
     Ever Owned → Intent to Own  .355 .055  6.407 <.001* 
     Familiarity → Intent to Own .081 .035 2.307 .021* 
     Female → Intent to Own .188 .091 2.055 .040* 
 
Hypothesis 6a 
Hypothesis 6a stated that severity would be a stronger predictor of behavioral 
intent for respondents receiving the threat agency message than those receiving the 
human agency message. Because severity was only a significant predictor for intent to 
seek information about Narcan in the overall model, this relationship was used to test the 
hypothesis. Hypothesis 6a was supported. Severity was a significant predictor of intent to 
seek in the threat agency group (β = 0.39, SE = 0.15, p=.008, R2=0.29). However, 
severity was not a predictor in the human agency group (β = 0.18, SE = 0.14, p=.205, 
R2=0.24).   
Hypothesis 6b 
Hypothesis 6b stated that susceptibility would be a stronger predictor of 
behavioral intent for respondents receiving the threat agency message than those 
receiving the human agency message. All three behavioral intent variables were 
significantly predicted by perception of susceptibility in the overall model and were used 
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to address this hypothesis. Regarding the Narcan coupon code acceptance, the estimates 
were extremely close in both groups, with the human agency group (β = 0.07, SE = 0.03, 
p=.007, R2=0.16) only slightly higher than the threat agency group (β = 0.06, SE = 0.02, 
p<.008, R2=0.26). However, the statistical differences were too small to make a 
meaningful interpretation. For intent to seek information about Narcan, susceptibility was 
a stronger predictor in the human agency group (β = 0.52, SE = 0.14, p<.001, R2=0.24) 
than the threat agency group (β = 0.34, SE = 0.16, p=.030, R2=0.29). With intent to own 
Narcan, perception of susceptibility was slightly higher in the threat agency group (β = 
0.14, SE = 0.05, p<.001, R2=0.35) than it was in the human agency group (β = 0.11, SE = 
0.04, p=.006, R2=0.41). Differences were minimal.   
The results are mixed as susceptibility was a stronger predictor of Narcan code 
acceptance and intent to seek information about Narcan in the human agency group, but a 
stronger predictor of intent to own in the threat agency group. However, the only intent 
variable in which there was a large enough difference to make a statistically meaningful 
interpretation was intention to seek information about Narcan; intention to seek 
information favored the human agentic message, contradicting the predicted hypothesis. 
Therefore, hypothesis 6b was not supported. The results for the linguistic agency 
assignment groups are displayed in table 22. 
Table 22 Linguistic Agency Assignment Group Results 
Path  Estimate  S.E.  C.R.  p  
Threat Agency          
     Susceptibility →Accept Code  .060 .023 2.645 .008* 
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Table 22 Continued 
     System-efficacy →Accept Code  .095 .032 2.953 .003* 
     Ever Owned →Accept Code  .257 .050 5.113 <.001* 
     Severity →Intent to Seek  .394 .148 2.659 .008* 
     Susceptibility → Intent to Seek  .344 .159 2.165 .030* 
     System-efficacy → Intent to Seek  .322 .145 2.215 .027* 
     Susceptibility → Intent to Own  .225 .038 5.856 <.001* 
     Response-efficacy → Intent to Own  .141 .052 2.724 .006* 
     Ever Owned → Intent to Own  .381 .082 4.671 <.001* 
     Familiarity → Intent to Own .047 .035 1.359 .174 
     Female → Intent to Own .152 .089 1.708 .088 
Human Agency 
    
     Susceptibility → Accept Code  .070 .026 2.706 .007* 
     System-efficacy → Accept Code  .023 .035 0.646 .518 
     Ever Owned → Accept Code  .116 .031 3.750 <.001* 
     Severity → Intent to Seek  .180 .142 1.267 .205 
     Susceptibility → Intent to Seek  .517 .142 3.647 .001* 
     System-efficacy → Intent to Seek  .399 .158 2.522 .012* 
     Susceptibility → Intent to Own  .108 .039  2.745 .006* 
     Response-efficacy → Intent to Own .129 .055 2.358 .018* 
     Ever Owned → Intent to Own  .403 .053  7.624 <.001* 
     Familiarity → Intent to Own .089 .037 2.419 .016* 
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Table 22 Continued 
     Female → Intent to Own .026 .091 0.289 .773 
 
Hypothesis 7 
Hypothesis 7 predicted the perception of system-efficacy would be a positive 
predictor of behavioral intent. This hypothesis was partially supported. In the final model, 
the perception of system-efficacy positively predicted both the intent to accept the Narcan 
discount code (β = 0.05, SE = 0.02, p=.027, R2=0.20) and the intent to seek additional 
information regarding Narcan (β = 0.35, SE = 0.11, p<.001, R2=0.26). Specifically, for 
every unit increase in system-efficacy, there was a 0.05 unit increase in Narcan coupon 
code acceptance and a 0.35 unit increase in intent to seek more information. The 
perception of system-efficacy did not predict the intention to own Narcan in the future (β 
= 0.04, SE = 0.03, p<.130, R2=0.05).   
Hypothesis 8a 
Hypothesis 8a predicted that system-efficacy would be a stronger predictor in the 
gain-frame group when compared to the loss-frame group. This hypothesis was not 
supported. There was no meaningful difference in how system-efficacy predicted 
acceptance of the coupon code between the gain-frame group (β = 0.04, SE = 0.03, 
p=.273, R2=0.27) and the loss-frame group (β = 0.06, SE = 0.04, p=.072, R2=0.16). There 
was also no meaningful difference in how system efficacy predicted intent to seek 
additional information between the gain-frame group (β = 0.44, SE = 0.14, p=.002, 
R2=0.21) and the loss frame group (β = 0.32, SE = 0.16, p=.044, R2=0.34).  
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Hypothesis 8b 
Hypothesis 8b predicted that system-efficacy would be a stronger predictor in the 
group receiving the message with the “addict” label when compared to the group 
receiving the “victim” label message. This hypothesis was not supported. There was no 
meaningful difference in how system-efficacy predicted acceptance of the coupon code 
between the “victim” group (β = 0.06, SE = 0.03, p=.074, R2=0.15) and the “addict” 
group (β = 0.05, SE = 0.04, p=.173, R2=0.24). There was also no meaningful difference 
in how system efficacy predicted intent to seek additional information between the 
“victim” group (β = 0.31, SE = 0.15, p=.041, R2=0.28) and the “addict” group (β = 0.41, 
SE = 0.15, p=.006, R2=0.25).  
Hypothesis 8c 
Hypothesis 8c predicted that system-efficacy would be a stronger predictor in the 
group receiving the threat agency message when compared to the group receiving the 
human agency message. This hypothesis was partially supported. Perception of system-
efficacy significantly predicted Narcan code acceptance in the threat agency group (β = 
0.10, SE = 0.03, p=.003, R2=0.26) but not in the human agency group (β = 0.02, SE = 
0.04, p=.518, R2=0.16). This was the only instance where perception of system-efficacy 
was significantly impacted by a message manipulation. There was no meaningful 
difference in how system-efficacy predicted intent to seek additional information between 
the threat agency group (β = 0.32, SE = 0.15, p=.027, R2=0.29) and the human agency 
group (β = 0.40, SE = 0.16, p=.012, R2=0.24). All system-efficacy statistics are displayed 
in table 23.  
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Table 23 Results for System-efficacy in Overall Model and Each Group 
Path  Estimate  S.E.  C.R.  p  
Overall Model          
     System-efficacy → Accept Code  .053  .024  2.211  .027*  
     System-efficacy → Intent to Seek  .355  .107  3.307  <.001*  
Gain-Frame          
     System-efficacy → Accept Code  .035 .032  1.095  .273  
     System-efficacy → Intent to Seek  .441 .141  3.123  .002*  
Loss Frame          
     System-efficacy → Accept Code  .064 .036  1.796  .072  
     System-efficacy → Intent to Seek  .317 .158  2.011  .044*  
Victim Label          
     System-efficacy → Accept Code  .056 .032  1.786  .074  
     System-efficacy → Intent to Seek  .305 .149  2.043  .041*  
Addict Label          
     System-efficacy → Accept Code  .049 .036  1.362  .173  
     System-efficacy → Intent to Seek  .412 .152  2.722  .006*  
Threat Agency          
     System-efficacy → Accept Code  .095 .032 2.953 .003*  
     System-efficacy → Intent to Seek  .322 .145 2.215 .027*  
Human Agency          
     System-efficacy → Accept Code  .023 .035  0.646  .518  
 
 81 
Table 23 Continued 
     System-efficacy → Intent to Seek  .399 .158  2.522  .012*  
 
Research Question 1 
Research question 1 asked if any other main effects or significant interactions 
exist for the three message manipulations (gain-frame/loss-frame message manipulation, 
victim/addict labeling manipulation, and linguistic assignment of agency). Results 
revealed that the interaction between gain/loss and victim/addict for intent to own were 
significant (F(1,297)= 6.510, p=.011). Specifically, participants who read a message with 
the gain-frame and the “addict” labeling manipulations had significantly higher intent to 
own Narcan than other combinations (Figure 8).    
Results also revealed that the interaction between the “victim/addict” labels and 
linguistic agency for Narcan coupon code acceptance and intent to own Narcan in the 
future were significant (F(1,297)=3.858, p=.050; F(1,297)=4.166, p=.042). Specifically, 
participants who received a message with the “addict” label and human agency 
manipulations were significantly more likely to accept the Narcan discount code (figure 
9) and indicate intent to own Narcan nasal spray (figure 10). Finally, the interaction 
between all three manipulations for system efficacy was significant (F(1,297)=4.524, 
p=.034) (Figure 11). Specifically, the message with the loss-frame manipulation, “addict” 
label, and threat agentic message was significantly higher than the gain-frame, “victim” 
label, human agentic message. 
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Figure 8. Framing and Label Interaction Effect on Intent to Own 
 
Figure 9. Label and Linguistic Agency Interaction Effect on Code Acceptance 
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Figure 10. Label and Linguistic Agency Interaction Effect on Intent to Own 
Several other findings unrelated to the hypotheses emerged when comparing the 
gain-frame and loss-frame groups. Perception of susceptibility significantly predicted 
participants’ Narcan code acceptance in the loss-frame group (β = 0.87, SE = 0.26, 
p<.001, R2=0.13) but not in the gain frame group (β = 0.31, SE = 0.02, p=.181, R2=0.09). 
Also, perception of severity significantly predicted intent to seek more information 
concerning Narcan in the loss-frame group (β = 0.32, SE = 0.13, p=.015, R2=0.27), but 
not in the gain-frame group (β = 0.18, SE = 0.14, p=.194, R2=0.14). 
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Figure 11. Label and Gain-Loss Interaction Effect on Agency Plots for System-Efficacy  
Extraneous Variables 
Demographics 
In the final model, only one demographic (gender) served as a significant 
predictor. Specifically, female respondents were more likely to indicate a belief that they 
would own Narcan in the future (β = 0.13, SE = 0.07, p=.043, R2=0.38). Other 
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demographics including age, race, and ethnicity were not significant predictors of any 
dependent variable, nor did they improve overall model fit. 
Correlates 
This study controlled for five separate correlates that the researcher anticipated 
having high likelihood of predicting the dependent variables. Of these, two correlates did 
in fact significantly predict behavioral intent. Specifically, previous ownership of Narcan 
predicted intent to own Narcan in the future (β = 0.38, SE = 0.04, p<.001, R2=0.38), as 
well as discount code acceptance (β = 0.15, SE = 0.03, p<.001, R2=0.20). Also, 
familiarity with Narcan significantly predicted intent to own Narcan in the future (β = 
0.06, SE = 0.03, p=.017, R2=0.38).
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CHAPTER V – DISCUSSION 
The purpose of this project was to test messages that persuaded people to 
purchase Narcan nasal spray using the EPPM as the guiding framework. The messages 
were manipulated three ways, including message framing, labeling, and linguistic agency 
assignment techniques. Additionally, optimistic bias and system-efficacy were measured 
and tested alongside the constructs of the EPPM. The discussion of the study results is 
summarized in the following sections (EPPM, optimistic bias, gain-frame/loss-frame, 
labeling, linguistic agency assignment, and message manipulation interactions). An 
exploration of limitations, future research, and concluding thoughts are also included.  
The first measure of behavioral intent, which was acceptance or refusal of the 
coupon code for Narcan nasal spray, was predicted only by susceptibility and system-
efficacy. The second measure, intent to seek additional information regarding Narcan, 
was predicted by severity, susceptibility, and system-efficacy. The third measure, intent 
to own Narcan in the future, was predicted by susceptibility and response-efficacy. 
Optimistic bias and self-efficacy did not predict any of the three behavioral intent 
variables. However, when separate from the other independent variables, optimistic bias 
predicted all three behavioral intent variables. Message manipulations effects are 
summarized in table 24. 
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Table 24 Message Manipulation Effects 
 Group in which variable is stronger predictor 
Path Framing Label Agency 
Susceptibility→Accept Code Loss-frame - - 
Susceptibility→Seek - - Human agency 
Susceptibility→Future Own - - - 
Severity→Seek Loss-frame “Victim” Threat agency 
Response Efficacy→Future Own Loss-frame “Addict” - 
System Efficacy→Accept Code - - Threat agency 
System Efficacy→Seek - - - 
 
EPPM 
Susceptibility as the key predictor 
Of the predicting variables, only susceptibility was a predictor of all three 
behavioral intent indicators. System-efficacy successfully predicted two of the three 
variables, and severity and response-efficacy predicted just one of three. Therefore, 
susceptibility remains an integral, and perhaps the most integral, part of crafting 
messages for health communication campaigns. Because an individual is unlikely to heed 
a recommendation to avoid a danger that they do not think is threatening to them or to 
their loved ones, messages should focus on perceived susceptibility. As the number of 
opioid overdoses has risen since the nineties, it is possible that one reason for this 
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increase is the lack of perceived susceptibility Americans have, especially towards others 
such as loved ones.   
The first proposition of the EPPM claims that a failure to increase threat 
perceptions will prevent further processing of the message, rendering efficacy 
perceptions irrelevant (Witte, 1992). Not surprisingly, because susceptibility was the 
strongest predictor, response-efficacy and self-efficacy were the weakest predictors. This 
finding also supports Ruiter and colleagues’ (2014) argument that susceptibility is more 
important to overall threat perception than severity. The current study also reveals that 
perceived threat to others motivates people to act in a similar way as a perceived threat to 
self (Sampson et al., 2001). In this case, although the message does not focus on the death 
of the individual receiving the message, it is still effective at motivating them to accept 
the recommended behavior change.   
Threat perception as a predictor of information seeking behavior 
The intention to seek additional information about Narcan nasal spray was 
predicted by high perceptions of both severity and susceptibility. Self-efficacy and 
response-efficacy were not significant predictors of intention to seek more information. 
One explanation for this result is that respondents’ who already perceived Narcan nasal 
spray as an efficacious response did not need additional information before deciding 
whether to heed the recommendation. However, those respondents reporting heightened 
threat perceptions who were not convinced that Narcan nasal spray was an effective 
response were left wanting more information than what was given them in the message. 
This finding reiterates that in order for a message to be completely effective, respondents 
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should have high perceptions of response efficacy. Simply convincing a person that he is 
in danger is ineffective by itself.  
Response-efficacy as a predictor of intent to own Narcan nasal spray 
Response-efficacy was a significant predictor of intent to own Narcan. However, 
response-efficacy was not a significant predictor of accepting the Narcan discount 
coupon code. Although participants indicated an intention to own Narcan after reading 
the messages, the insignificant finding for accepting the Narcan discount code reveals a 
lack of urgency among respondents who intended to purchase the drug. A possible 
explanation for this lack of urgency may be weaker perceptions of severity among 
respondents who reported feeling susceptible. Perceived susceptibility was a significant 
predictor of intent to own Narcan and intent to accept the Narcan discount code. 
However, perceived severity predicted neither of the behavioral intention indicators. 
Therefore, many participants perceived their loved ones susceptible to opioid overdoses 
while also perceiving Narcan nasal spray as an effective response; however, respondents 
did not view the threat so severe as to want to purchase the drug immediately. The lack of 
urgency is problematic because fear appeal messages tend to have weaker impact on 
long-term behavior (Hastings & Stead, 2004). Participants who reported both an intent to 
purchase Narcan but a subsequent refusal to purchase immediately will likely never 
obtain the life-saving medication unless they encounter additional pro-Narcan messages 
later.  
The absence of self-efficacy as a predictor of behavior 
The inability of self-efficacy to predict behavioral intention was an unexpected 
finding, particularly because the EPPM positions self-efficacy as a direct antecedent of 
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behavioral intention. However, the current study deviates from other studies that measure 
the relationship between self-efficacy and behavioral intention. In the current study, the 
danger communicated (loved ones overdosing) was likely perceived as a threat to others 
and not a perceived threat to self. Although the message attempts to raise the awareness 
that opioids could harm ‘your loved ones’ and not 'you,’ the unique message 
manipulation likely affected participants’ perceptions of self-efficacy in an unintended 
way. These results seem to indicate that if a threat does not impact a person directly, self-
efficacy may not play a significant role in his or her behavioral intentions. 
Optimistic Bias 
The overly optimistic perception of loved ones 
Results of the current study confirm what much of the optimistic bias literature 
posits, which is an overwhelmingly optimistic feeling that loved ones will not overdose 
on opioids. The unique finding in this study is that optimism was not a perception about 
oneself, but rather a perception toward others. Therefore, what is the relational 
“closeness” required for people to feel optimistic bias for others? Do people feel 
optimistic bias for only loved ones, or can optimistic bias also be experienced for 
coworkers or simple acquaintances? Instead of viewing optimistic bias as simply ‘me 
compared to everyone else,’ there may be merit in considering the role of optimistic bias 
in our relationships with others. Maybe the strongest feelings of optimism are for one’s 
self, followed by close family, then friends, etc. There is likely some degree of 
relationship strength (perhaps a simple acquaintance) where we no longer feel optimistic 
about that person’s susceptibility to a threat.  
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The exclusion of optimistic bias from the EPPM 
When included with the variables of the EPPM (severity, susceptibility, response-
efficacy, and self-efficacy), optimistic bias was not a significant predictor of any 
behavioral intention items. However, optimistic bias by itself significantly predicted all 
three items rather conclusively. Based on the current study, optimistic bias does not fit in 
the structure of the EPPM, likely because of its theoretical similarity to susceptibility. In 
fact, Turner, Skubizs, and Rimal (2011) describe optimistic bias as a difference in 
perceptions of susceptibility. Therefore, the inclusion of optimistic bias in the EPPM is 
redundant and unwarranted.  
Perhaps the only time that optimistic bias should be used in lieu of the perception 
of susceptibility is if there is a distinct comparison being made between two individuals 
or groups. For example, if the purpose of a message was to convince the female 
population that they are as susceptible to opioid addiction as the male population, then 
optimistic bias could be used to measure the effectiveness of the message instead of 
simply the perception of susceptibility. However, when this is not the case, a 
measurement of optimistic bias is unnecessary.  
Optimistic bias as a predictor of behavior 
Regardless of its exclusion from the EPPM, optimistic bias alone serves as a 
significant predictor of behavioral intent. Just as the perception of susceptibility 
significantly predicted of all three intent variables, so too did optimistic bias when alone. 
When discussing the opioid crisis., those tasked with communicating the seriousness of 
the epidemic must convince message recipients that negative side effects of opioids could 
very well affect them and their loved ones. Additionally, message designers should go a 
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step further in convincing members of the public that they are not less overdose 
susceptible when compared with the average person.   
Gain-Frame/Loss-Frame 
Loss-frame increases response-efficacy perceptions but not self-efficacy perceptions 
This study predicted a significant difference in regard to efficacy perceptions 
between participants receiving a gain-frame message and those receiving a loss-frame 
message. Previous scholarship indicated that perceptions of efficacy, and self-efficacy in 
particular, are impacted by whether messages are gain-framed or loss-framed (Van’t Riet, 
Ruiter, Werrij, & De Vries, 2008; Van’t Riet, Ruiter, Werrij, & De Vries, 2010; Werrij, 
Ruiter, Van’t Riet, & De Vries, 2011). However, self-efficacy did not predict behavioral 
intention in the current study; only the path from response-efficacy to intention to seek 
additional information was statistically significant. Perhaps if self-efficacy had remained 
a statistically significant predictor in the model, message framing may have impacted its 
predictive strength. Regardless, the results of this study show that framing a message in 
terms of potential losses will increase the predictive power of response-efficacy.   
Using a loss-frame impacts perceptions of threat 
One important finding that resulted from the framing manipulation was that threat 
perceptions predicted behavioral intent better in the loss-frame group. Specifically, the 
path from perceived susceptibility to Narcan coupon code acceptance and the path from 
severity to intent to own Narcan were statistically significant only in the loss-frame 
group. One explanation for this finding is that loss-frame messages may have made death 
seem like a more likely outcome because it emphasized the likelihood of it actually 
happening (i.e. “he or she will likely die”). Also, a sense of urgency was likely 
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communicated better in the loss-frame message as well (i.e. “Your loved one could be 
next”). When attempting to increase the perception of danger concerning opioids, a 
message designer should have more success if he or she emphasizes potential losses 
rather than the possibility of avoiding the loss. It is important to note here that this may 
not have been the case if a desirable kernel state had been used in the messages as 
opposed to the undesirable kernel state.    
The model fit is better in the loss-frame message 
Overall, the model was more effective at predicting behavioral intent in the loss-
frame message. This finding may be explained through considering message kernel 
states. The researcher decided to only employ an undesirable consequence as the kernel 
state in both the gain-frame and loss-frame messages. The result of purchasing or not 
purchasing Narcan nasal spray resulted in either a negative event happening (loved one 
dying) or a negative event not happening (loved one not dying). A desirable consequence 
was never used as the kernel of the message, as there are practically no desirable 
consequences of purchasing Narcan other than the avoidance of negative consequences.    
However, looking past the potential limitation of only having one kernel state, the 
EPPM posits that if threat perceptions are low, then no further processing of the message 
will occur. The threat perceptions were significantly worse predictors of behavioral intent 
in the gain-frame message. Therefore, many respondents who received the gain-frame 
message likely did not completely process the fear appeal. At first glance, this appears to 
run contrary to the assumptions of prospect theory which posit that people will choose 
options that present the potentials gains rather than potential losses (Tversky & 
Kahneman, 1981). However, the potential gains likely need to be more compelling than 
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simply avoiding negative consequences. Perhaps an absence of loss does not constitute a 
gain. If this is true, then a message focused on saving a life, like the gain-frame messages 
used in this study, should not be considered a gain-frame message because it does not 
have tangible gains. Maybe instead, it should be considered a framing technique that 
focuses on maintaining the norm. 
Labeling 
The ability of the ‘victim’ label to increase severity perceptions 
Severity was a significant predictor of behavioral intent only in messages 
employing the term “victim” rather than “addict.” Of the two labels, “victim” appears to 
be less stigmatizing; being deemed a “victim” implies a lack of control over the situation. 
Pragmatically, “victim” is a word usually employed only in serious situations of harm or 
injury. For example, persons suffering from domestic abuse are often called victims, but a 
child kicked by another child at recess would likely not be described as a “victim.” 
Therefore, messages employing the “victim” label will likely lead to higher perceptions 
of severity. 
The Ability of the ‘Addict’ Label to Increase Response-Efficacy Perceptions 
Although messages employing the term “victim” were helpful in increasing 
perceived severity, response-efficacy was only a predictor of behavioral intention in 
messages employing the term “addict.” The label “addict” was intended to be a more 
stigmatizing label. Being labeled an “addict” implies both personal responsibility and a 
lack of individual control. Interestingly, the “addict” label appeared to cause the audience 
to perceive that Narcan nasal spray was an effective response to an overdose, more so 
than the “victim” label. This may be because of the sense of finality that the word victim 
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connotes. As discussed above, the term victim is usually reserved for serious incidents 
that likely have already taken place. A victim may be perceived as already being dead for 
instance. Narcan, in this case, would not be an effective remedy. However, labeling 
someone an addict does not similarly indicate that it is too late, or that he has already 
passed away. If the addict is still alive, then being prepared with Narcan in case he does 
overdose would appear to be an efficacious response.  
Labels should be carefully considered based upon intended perception 
With severity and response-efficacy having mixed results in terms of labeling, the 
question remains as to which label should be used when designing messages. The answer, 
according to the data from this study, is that they should be interchanged depending on 
the purpose of each statement within the message. Statements trying to invoke a sense of 
danger should use the “victim” label (i.e. everyone around you is a potential victim to the 
opioid crisis). Statements trying to invoke a sense of efficacy should use the “addict” 
label (i.e. Narcan nasal spray can revive addicts who have overdosed). For instance, a 
situation where the intended audience likely knows little about the dangers of opioids, 
such as adolescents, would need to be convinced of the severity of the threat. Conversely, 
first responders may need only to be convinced of the effectiveness of Narcan. The label 
used should be dependent on the purpose of the message and which audience perceptions 
are desired. Further research should confirm that this strategy is effective.   
Linguistic Agency Assignment 
The perception of severity is higher in threat agentic messages 
As anticipated, severity was only predictive of behavioral intent when agency was 
assigned linguistically to the threat (i.e. “opioids killed” instead of “Americans died”). 
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This adds to the body of literature that argues linguistically assigning a threat with 
agency, rather than a human, prompts readers to perceive the threat as more serious and 
will likely cause them to be more supportive of actions protecting the public from the 
threat (McGlone, Bell, Zaitchik, & McGlynn III, 2013; Bell, McGlone, & Dragojevic, 
2014a; Bell, McGlone, & Dragojevic, 2014b; Dragojevic, Bell, & McGlone, 2014; 
Glowacki, McGlone, & Bell, 2016). This reinforces the argument that linguistic agency 
assignment is a significantly effective tactic at persuading people that a threat is harmful. 
This is very useful for agencies or communication practitioners who have the task of 
convincing others to act in potentially harmful situations. For example, communities that 
have experienced a high number of hurricane warnings may be harder to motivate to 
evacuate because of low threat severity perceptions (Anthony & Sellnow, 2011).  
The perception of susceptibility in human agentic messages predicts information seeking 
behavior 
While the current findings regarding severity align with past research, the current 
findings for susceptibility are at odds with many previous studies. In the current study. 
susceptibility was revealed a stronger predictor of behavioral intent in messages where 
agency was linguistically assigned to humans. Chen, McGlone, and Bell (2015) also 
found agency assignment to humans, rather than to colon cancer, elevated perceptions of 
susceptibility. Chen et al. (2015) argued, “This unexpected finding might be explained by 
the locus of the threats studied to date” (p. 984). They continue, “Bacteria, viruses, and 
radon gas emanate from outside people and come to them to produce harm. In contrast, 
colon cancer originates from within the person; indeed, the threat is the person’s own 
mutating cells” (p. 984).   
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The findings of the current study lend support to Chen et al.’s (2015) use of locus 
as the predictor of perceptions of susceptibility. While opioids do not originate in the 
human body like cancer cells, individuals make the decision to consume opioids, whether 
prescription or illicit. Addiction can also be considered an internal threat. Additionally, 
those who are addicted to opioids may take doses that they know are dangerous. The 
decision to use the drug recreationally or take a dosage higher than recommended is made 
internally. On the other hand, a bacterium, virus, or radon gas can endanger unsuspecting 
individuals without any action taken or consent provided by the person. Instead, the 
current study focuses on addiction and the conscious decision made by individuals who 
knowingly risk ingesting opioids.   
System-Efficacy 
The perception of system-efficacy is a strong predictor of behavior 
Although not an original construct in Witte’s (1992) EPPM, the perception of 
system-efficacy served as a strong predictor of behavioral intent in the current study. As 
discussed above, system-efficacy was significant in the final model while self-efficacy 
was not a significant predictor of behavioral intent. This finding is noteworthy for future 
EPPM studies. While the current study is not arguing for system-efficacy to replace self-
efficacy as a staple construct in the EPPM, our findings suggest when a perceived threat 
is more likely to affect individuals external to the individual, such as loved ones, system-
efficacy is a better predictor of behavioral intent than self-efficacy. For example, if the 
messages in this study had attempted to persuade readers to dispose of old opioid to avoid 
potential self-harm, perhaps self-efficacy would have been a stronger predictor of 
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behavioral intention than system-efficacy. However, because the potential threat was the 
death of a loved one, self-efficacy was no longer salient to the participants. 
To better understand how system-efficacy affected the outcome variables in this 
study, it is imperative to understand what respondents perceived as “the system”. The 
system in this case, based upon the items from the survey, represented several different 
entities that can serve to protect loved ones, including organizations or agencies that want 
to protect the public from the opioid crisis, the government, friends and family, 
pharmaceutical researchers, and scientists. It was respondents’ perceptions of these 
entities, and their ability to protect the respondents’ loved ones, that made up the 
perception of system-efficacy.  
The lack of salience of self-efficacy among participants may have resulted from 
the little control individuals perceive they have in protecting loved ones. For instance, if a 
mother sends her child to school on the bus, she has lost the ability to protect the child 
from harm during the commute to school; she now must rely on a variety of others to 
protect the child, including the bus driver, school teachers, and even other children. The 
likelihood of the child’s safe return home is completely out of the control of the mother, 
and her perception and confidence that her child will return safely can be operationally 
defined as system-efficacy. In the context of health communication campaigns, if the 
recommended behavior or attitude change is intended to protect others from a threat 
rather than oneself, an emphasis on system-efficacy in campaign messages may serve as a 
stronger predictor of intention to accept the recommendation than self-efficacy.   
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Threat agentic messages increase the power of system-efficacy perceptions 
The threat agentic message rather than the human agentic message was the only 
message manipulation that significantly increased perceptions of system-efficacy. Giving 
opioids agency resulted in system-efficacy being a predictor of behavioral intent. Threat 
agency language removes the power of action from the individual, and as explained in the 
example of the mother sending her child to school, when a person perceives that she has 
lost personal control, she will tend to rely more heavily on the greater system. Therefore, 
the finding of threat agentic messages increasing system-efficacy perceptions further 
advances the importance of using system-efficacy over self-efficacy when the message 
communicates a threat to others. 
Message Manipulation Interactions 
System-efficacy thrives in the loss-frame/addict/threat agency message 
Three significant interactions were found between message manipulations. The 
first interaction, and the only one that included a combination of all three manipulations, 
revealed that the loss-frame/“addict” label/threat agentic (LAT) message resulted in the 
highest perceptions of system-efficacy. This finding supports the argument for the 
inclusion of system-efficacy when the threat affects the individual indirectly. When the 
danger is a perceived threat to others and not to the self, system-efficacy is more 
important than self-efficacy in predicting behavioral intent. In the LAT message, all three 
manipulations take control away from the individual. While the loss-frame message 
likely produces images of overdosed, and even dead loved ones, the addict label likely 
conjures images of helpless loved ones. Additionally, using threat agency takes ability 
away from the human. All three message characteristics take power away from the 
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message recipient. Therefore, they must put their trust in the hands of the system, rather 
than themselves. This could explain why the LAT message led to the highest levels of 
perceived system-efficacy.   
The ‘addict’ label in a gain-frame message significantly increases intent to own Narcan 
The second interaction was between “addict” and “victim” labeling and gain-
frame/loss-frame messages. Behavioral intent was significantly increased when the 
“addict” label was employed in a gain-frame message. An example phrase employing 
both tactics is, “you can save the life of an addict by using Narcan nasal spray.” As 
mentioned above, response-efficacy was significantly increased in the “addict” labeled 
messages. The combination of the heightened response-efficacy perception (through the 
“addict” label) with the perception of a positive outcome (resulting from gain-framing) 
resulted in a significantly higher likelihood of intending to own Narcan nasal spray.  
The interaction effects between the “addict” label and gain-frame messages 
deviates from the main effects of the study because on the whole, the loss-frame message 
was more likely to increase behavioral intent than the gain-frame message. When 
combined with the “addict” label however, the gain-frame message was more salient. 
There may be an incongruency between the “victim” and the gain-frame message. The 
“victim” label implies the negative event has already happened and saving him is less 
likely to happen. Alternatively, the “addict” can still be saved, and has not yet become a 
victim through overdosing on opioids, and possibly even death.   
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The ‘addict’ label in a human agency message significantly increases intent to own and 
accept the discount code for Narcan 
The final significant interaction occurred in the messages employing the “addict” 
label in human agentic phrasing (i.e. when addicts ingest too many opioids, their 
breathing is suppressed, and they suffocate). The notion that opioids independently 
caused the overdose (threat agency) and the idea of the individual’s addiction causing the 
overdose (“addict” label) are mutually exclusive. Giving opioids agency in suffocating a 
person positions the drugs as an active assailant and the individual as a victim rather than 
an addict. This contradiction of responsibility may negatively impact the processing of 
the message, and ultimately, the perceptions of threat and efficacy. To avoid this, a 
message that employs the victim label should be ascribing agency to the threat. Further 
research should seek to better understand this finding. 
Demographics 
Gender predicts intent to own Narcan 
As the only demographic variable that predicted behavioral intent, female 
participants were significantly more likely to indicate an intent to own Narcan in the 
future. One potential explanation for this finding is gender and risk aversion. Rosen, Tsai, 
and Downs (2003), for example, found female participants to have significantly higher 
rates of risk aversion than male participants when imagining different health states. 
Therefore, a stronger desire to avoid health risks among female participants could 
certainly explain the higher intent to own Narcan. 
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Limitations 
One limitation of the current study was that all messages had an undesirable 
consequence kernel state, regardless of whether a gain-frame or loss-frame was 
employed. This decision was made because loss of life (or preventing loss of life) is the 
primary reason that Narcan is ever used in overdose situations. Therefore, only the 
undesirable kernel state was used.  
Second, although reading checks, attention checks, and time requirements were 
implemented to protect the dataset from “careless” participants, there still may have been 
a small number of respondents who took the survey with some degree of carelessness. 
There is a possibility that some participants read only the parts of the message that they 
needed to answer the reading check questions correctly. However, even if the minimal 
amount of reading was done, the checks ensured that all manipulations were read and 
processed.  
Third, because participants across the United States were sampled, there was 
likely a difference in perception of the opioid crisis between participants prior to taking 
the survey. For example, participants from the Midwest or Southeast, areas of the country 
where the epidemic has hit the hardest, and participants from the West Coast may have 
had different initial perceptions of severity and susceptibility before reading the study 
message. Location was not controlled for in the analysis, and therefore could have 
impacted the results to some degree.   
Fourth, only two labels were used to test stigmatization through language. While 
“victim” and “addict” certainly shed light on this discussion, several other labels could 
have been used such as “user”, and “abuser”, or even more extreme labels such as 
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“crackhead”. There are many ways that individuals who abuse opioids can be negatively 
stigmatized through language, and each may affect message processing in a different 
way. In order to get a firm grasp on how stigmatizing labels impact perceptions of 
individuals who have overdosed, a broader pool of labels need to be tested. 
Future Research 
Based on the results of the current study, five areas for potential future research 
are offered. First, one of the primary findings of the current study is that system-efficacy 
is a better predictor of behavioral intention than self-efficacy when the danger is 
perceived more as a threat to others than a threat to oneself. Additional studies should 
further investigate the difference between perceptions of system-efficacy and self-
efficacy, and in what circumstances system-efficacy may be a better predictor of 
behavior. For instance, two fear appeal messages focused on the same threat could be 
helpful in this endeavor. If one message positioned the threat as affecting others (external 
to the individual) while the other positioned the threat as directly affecting the individual, 
the researcher could then compare the two groups. 
A second argument requiring further research focuses on the interplay of levels of 
optimistic bias and the degree of relationship. Based on the findings of the current study, 
if a less intimate relationship exists between the respondent and the person in danger, the 
optimistic bias should be lower. Alternatively, if the relationship is more intimate, 
individuals will experience higher levels of optimistic bias when confronted with 
potential threats to persons close to them. Future research should measure optimism for 
one’s self, optimism for family members, optimism for friends, optimism for co-workers, 
and so on. Results could determine if optimistic bias increases with intimacy.   
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Third, the current study revealed the “addict” label increased perceptions of 
response-efficacy among respondents while the “victim” label increased perceptions of 
severity. It was argued in this study that both labels should be employed in the 
appropriate places throughout the message to increase both perceptions. However, it is 
unknown if there would be unintended consequences of doing so. For instance, if a 
message labeled people as victims in one sentence and addicts in another, the processing 
of both labels may interact negatively, decreasing behavioral intent likelihood. Therefore, 
a message should be created using this strategy to see if the results play out as 
anticipated, or if the negative interaction occurs.   
Finally, the interaction between the “addict” label and the human agentic message 
resulted in a higher intent to change behavior. The two possible explanations 
hypothesized here include 1) the idea that addiction as the cause and opioid agency as the 
cause are mutually exclusive, and 2) that the “addict” label and the human agency 
message independently raised susceptibility. Further research should attempt to clarify 
which hypothesis is a better explanation. How these language variables interact needs to 
be parsed out further. 
Conclusion 
The purpose of the current study was to identify message strategies for persuading 
people to purchase Narcan. Based on the findings from this study, a final version of the 
message was created with the recommended characteristics (Figure 12). In instances 
where the message should increase threat perceptions, a loss-frame is employed (i.e. 
“opioid victims are dying”). The “victim” label is used in instances where perceptions of 
severity should be increased (i.e. “Opioid pills and heroin killed over 63,000 victims”). 
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The “addict” label is used in instances where response-efficacy should be increased (i.e. 
“When an addict has overdosed, spray Narcan into their nostrils or they could die”). 
Threat agency assignments are made in instances where severity is to be increased (i.e. 
“An opioid overdose occurs when opioids take over the brain and suffocate the victim”). 
And human agency assignments are made in instances where susceptibility is to be 
increased (i.e. “People from all genders, races, and classes are overdosing on opioids”). 
This message represents the practical implications of this study.   
Theoretical implications affect several areas of research. System-efficacy and its 
possible inclusion in the EPPM under certain circumstances is an impactful finding. This 
increases scholarly understanding of how risk messages are processed, and what 
communication variables impact behavior. The way people are labeled and stigmatized in 
messages does carry consequences for message processing as well. Finally, the study 
sheds additional light on the way linguistic agency assignments impact perceptions of 
susceptibility. Specifically, a threat’s perceived locus may prevent threat agentic 
assignments from increasing susceptibility. 
In conclusion, the opioid crisis that has plagued America for over three decades 
has only become a larger problem with an increasing number of casualties. It will take a 
concentrated effort from every corner, including prescription and pharma regulation, 
addiction recovery, first response efforts, and more. What cannot be overlooked or 
understated is the importance that communication campaigns can have in reversing the 
epidemic. Education and awareness are at the heart of any public health initiative. The 
crisis will likely never be resolved without a better public understanding of the tools 
(such as Narcan) that are available to reconcile the issue. The results of this study can 
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inform message design for such campaigns. A knowledge of how small but important 
message characteristics, such as labels, agency, and framing, can impact threat and 
efficacy perceptions can significantly improve campaign outcomes. It will be attention to 
details, such as campaign messages and how they’re presented, that can save lives and 
end the opioid epidemic. 
 
Figure 12. Final Message with Study Recommendations 
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APPENDIX A – SURVEY INSTRUMENT 
Reading Validity Check Questions 
1. In the message above, what does the second line that is written in black say?  
 Answer options dependent on message assigned 
2. How many victims does the message say were killed by opioid pills and heroin in 
2016? 
 a. Over 12,000 b. Over 5,000  c. Over 63,000 
3. In the message above, what does the first line that is written in pink say?  
 Answer options dependent on message assigned 
Attention Validity Check Question 
1. I am taking a survey. 
 1 (Strongly Disagree) – 6 (Strongly Agree) 
Optimistic Bias Items 
1. What are the odds that one of your loved ones will overdose on opioids or heroin? 
 0 (Not likely at all) - 10 (Extremely likely) 
2. What are the odds of that the average person will overdose on opioids or heroin?
 0 (Not likely at all) - 10 (Extremely likely) 
Self-Efficacy Scale 
1. Narcan nasal spray is easily available to me.  
1 (Strongly Disagree) - 6 (Strongly Agree) 
2. I have the ability to use Narcan nasal spray if required.  
1 (Strongly Disagree) - 6 (Strongly Agree) 
3. There is nothing preventing me from using Narcan nasal spray.  
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1 (Strongly Disagree) - 6 (Strongly Agree) 
4. Narcan nasal spray is easy to use. 
Response-efficacy Scale 
1. Narcan nasal spray will prevent the death of a loved one who has overdosed. 
1 (Strongly Disagree) - 6 (Strongly Agree) 
2. My loved ones are less likely to die from an overdose if I have Narcan nasal spray.  
1 (Strongly Disagree) - 6 (Strongly Agree) 
3. Narcan nasal spray is effective in ending the threat of a loved one dying from an 
overdose. 
1 (Strongly Disagree) - 6 (Strongly Agree) 
4. If someone has overdosed on opioids, I believe Narcan nasal spray can save them. 
 1 (Strongly Disagree) - 6 (Strongly Agree) 
System-efficacy Scale 
1. I believe there are organizations or agencies that want to protect me from the opioid 
crisis. 
1 (Strongly Disagree) - 6 (Strongly Agree) 
2. The government will help me respond to the opioid crisis. 
1 (Strongly Disagree) - 6 (Strongly Agree) 
3. My friends and family will protect me from the opioid crisis. 
1 (Strongly Disagree) - 6 (Strongly Agree) 
4. Pharmaceutical researchers and scientists want to protect me from the opioid crisis. 
1 (Strongly Disagree) - 6 (Strongly Agree) 
  
 109 
Threat Severity Scale 
1. Opioids pose a serious risk to my loved ones. 
1 (Strongly Disagree) - 6 (Strongly Agree) 
2. Opioids are potentially harmful to my loved ones. 
1 (Strongly Disagree) - 6 (Strongly Agree) 
3. Opioids are a severe threat to my loved ones. 
1 (Strongly Disagree) - 6 (Strongly Agree) 
4. My friends could die from using opioids.  
 1 (Strongly Disagree) - 6 (Strongly Agree) 
Threat Susceptibility Scale 
1. My loved ones are at risk for being an opioid overdose victim. 
1 (Strongly Disagree) - 6 (Strongly Agree) 
2. It is possible that one of my loved ones will overdose on opioids. 
1 (Strongly Disagree) - 6 (Strongly Agree) 
3. I believe that one of my loved ones could be a victim of the opioid crisis. 
1 (Strongly Disagree) - 6 (Strongly Agree) 
4. An opioid overdose could happen to one of my loved ones. 
 1 (Strongly Disagree) - 6 (Strongly Agree) 
Behavioral Intent 
1. Helprx.info is currently offering a 75% off coupon for Narcan. Would you like a link 
to this offer?  
 Yes No 
2. Do you think you will ever own Narcan nasal spray?  
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 Definitely Not  Probably Not  Probably Yes  Definitely Yes 
3. Do you plan on seeking more information about opioids or Narcan nasal spray? 
 Definitely Not  Probably Not  Probably Yes  Definitely Yes 
4. How likely are you to seek information about Narcan nasal spray? 
 1 (Extremely unlikely) - 7 (Extremely likely) 
Correlates 
1. Have you ever owned Narcan nasal spray? 
Definitely Not  Probably Not  Probably Yes  Definitely Yes 
2. Have you ever used Narcan nasal spray?  
 Definitely Not  Probably Not  Probably Yes  Definitely Yes 
3. Has someone close to you ever overdosed on opioids or heroin?  
 Definitely Not  Probably Not  Probably Yes  Definitely Yes 
4. Before taking this survey, did you know what Narcan nasal spray was?  
 Definitely Not  Probably Not  Probably Yes  Definitely Yes 
5. How familiar were you with Narcan nasal spray prior to taking this survey? 
 1 (Not familiar at all) - 5 (Extremely familiar) 
Demographics 
1. What best describes your sex?  
Male  Female Other or prefer not to disclose 
2. What best describes your race? 
 White  
Black or African American  
Asian 
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American Indian or Alaska Native  
Native Hawaiian or Pacific Islander 
Other 
3. What best describes your age?  
 18-24 25-34 35-44 45-54 55-64 65-74 75+ 
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APPENDIX B – STUDY MESSAGES 
 
 Gain-Frame/Addict/Human Agency Message 
 
 Gain-Frame/Addict/Threat Agency Message 
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 Gain-Frame/Victim/Human Agency Message 
 
 Gain-Frame/Victim/Threat Agency Message 
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 Loss-Frame/Addict/Human Agency Message 
 
 Loss-Frame/Addict/Threat Agency Message 
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 Loss-Frame/Victim/Human Agency Message 
 
 Loss-Frame/Victim/Threat Agency Message 
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